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1. Introduction 
 
“Having stolen the secret of fire from the gods of Olympus, Prometheus drew down 
on himself the anger of Zeus, the ruler of gods and men. Zeus punished Prometheus 
by chaining him to Mount Caucasus where he was tormented by an eagle. The eagle 
preyed on Prometheus’ liver, which was renewed as fast as it was devoured.” 
Adapted from Bulfinch’s Mythology 
 
1.1. Physiology and central function of the liver 
The liver is the largest glandular organ of the mammalian body. It plays a 
central role in metabolic homeostasis and it serves as the primary regulatory site for 
energy metabolism, synthesizes essential proteins, enzymes and co-factors for 
digestion and regulation of metabolic functions. Essential functions are formation and 
secretion of bile acid, regulation of ammonia, iron and bicarbonate homeostasis and 
synthesis of most plasma proteins. Additionally, the liver has an important role as the 
major detoxifying organ, eliminating a variety of endogenous and exogenous 
compounds. Finally, providing important immunologic function, the liver is the central 
organ for phagocytosis of macromolecules and microorganisms such as bacteria. As 
the first line of defence against ingested toxins and many infectious agents, the liver 
has evolutionarily conserved responses including the ability to regenerate and to 
protect itself against injury. Due to the extensive functions, the ultrastructure of the 
liver consists of various cell populations of complex organisation. The most abundant 
cell type by mass and number are hepatocytes constituting 80% of the lobular 
parenchyma and form the largest cell population in the liver. The hepatocyte is a 
polarized epithelial cell consisting of three different specialized membrane domains: 
the basolateral (sinusoidal), a specialized bile canalicular and the intercellular 
domain, containing tight junctions, gap junctions and desmosomes. In dependence 
on age, metabolic load, location of the cell and regenerative activity hepatocytes vary 
in shape and size. The typical shape of hepatocytes is an irregular polyhedral with a 
size ranging from 20 to 30 µm (Motta 1977; Motta 1984). The nucleus of the 
hepatocyte constitutes 5 to 10 percent of cell volume, is spherical in shape and 
contains one or more prominent nucleoli. Twenty-five percent of hepatocytes are 
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binucleate. The nuclear size is correlated with nuclear ploidy; approximately 15% of 
hepatocytes are tetraploid (Gupta 2000). Hepatocytes develop from a primitive 
precursor cell called hepatoblast derived from endodermal outgrowth of the hepatic 
diverticulum, which gives rise to hepatocytes and parenchymal cells. Characteristic 
for the hepatoblast is the synthesis of α-fetoprotein (AFP) starting in the human liver 
as early as day 19. In contrast, expression of the most prominent liver-specific 
secreted protein albumin starts later. The induction of albumin increases in parallel 
with the decrease of AFP gene expression. As the most typical marker for early 
stages of liver development the expression of AFP stops almost completely after birth 
(Sala-Trepat, Dever et al. 1979; Hatano, Nakata et al. 1992). The liver also consists 
of nonparenchymal cells, like resident immune cells including Kupffer cells, NK and 
NKT cells, T-lymphocytes and the population of mesenchymal cells, providing stellate 
cells, liver myofibroblasts and specialized cells like sinusoidal endothelial cells and 
cholangiocytes. In addition to these common cells, a last population of cells can be 
found in damaged livers only, the progenitors cells of the liver also called oval cells 
(Fausto 2004). 
 
1.2. Liver regeneration 
The healthy liver is a quiescent organ in terms of proliferation with a very low 
cell-turnover. However, after injury caused by surgical resection, chemicals or viral 
infections the liver can restore its mass and cell function due to hepatocyte 
proliferation. As a general rule, replication of existing hepatocytes is the quickest and 
most efficient way to generate hepatocytes for liver regeneration and repair. Oval 
cells usually replicate and differentiate into hepatocytes only when the replication of 
mature hepatocytes is delayed or entirely blocked (Wang, Foster et al. 2003). 
The most common method to study liver regeneration in rodents is partial 
hepatectomy (PH) of two-thirds (70%) of the liver as described by Higgins and 
Anderson (1931). This model allows the analysis of cell proliferation in vivo and 
enhances the understanding of regulating Cyclins and Cdks and the arrangement of 
protein complexes. 
Although the adult liver contains cells with "stem-cell" properties, regeneration 
is accomplished by replication of mature hepatocytes. The hepatocyte is a unique cell 
that is highly differentiated but remains capable of replication. After PH, the remaining 
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hepatocytes leave their quiescent state (G0), enter the cell cycle and proliferate, 
followed by the non-parenchymal cells (NPC). During this regenerative process, cells 
maintain their major morphologic features, have an active urea cycle, continue to 
metabolize drugs and synthesize albumin. 
In general terms, the replicative response of quiescent hepatocytes after 
partial hepatectomy involves multiple steps, each requiring different sets of controls 
and circuits. These steps start by DNA binding of transcription factors such as NF-κB 
or STAT3 and the rapid activation of proto-oncogenes and other genes that encode 
proteins of diverse functions (immediate early genes). Initiation of the regenerative 
response depends on IL-6 and TNFα, priming quiescent hepatocytes for progressing 
G0/G1 transition of the cell cycle (Diehl 2000; Streetz, Luedde et al. 2000). These 
initial events sensitize hepatocytes to growth factors that subsequently drive 
quiescent cells to G1 phase of the cell cycle. Progression of primed/competent 
hepatocytes through G1 and subsequent replicative cycling is depending on 
hepatocyte growth factor (HGF) and transforming growth factor-alpha (TGF-α) 
signaling. 
Through this regenerative capacity the liver is able to restore its liver mass in 
rodents within approximately 7-10 days after surgery within 10% of the original 
hepatic mass before hepatectomy (Fausto 2000; Fausto, Campbell et al. 2006). This 
extraordinary capacity for compensatory growth in response to conditions induced by 
toxic injury and physical or infectious cell loss is a tightly regulated process of both 
hypertrophy (increase in cell size) and hyperplasia (increase in the number of cells). 
Involving different liver cell populations liver regeneration is regulated by the interplay 
between growth factors, cytokines, extracellular matrix components and other 
regulators (Michalopoulos and DeFrances 1997; Fausto 2000; Fausto, Campbell et 
al. 2006). 
 
1.3. NF-κB, IKK2, Nemo and liver regeneration 
NF-κB plays a major role during liver regeneration and gets activated directly 
after PH. NF-κB nuclear translocation can be found already 30 minutes after PH and 
its activation lasts until 4-5 hours after PH (FitzGerald, Webber et al. 1995). The 
relevance of NF-κB has been highlighted by previous studies showing impairment of 
DNA synthesis in TNFR1 knockout mice which exhibit lack of STAT3 and NF-κB 
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activation (Yamada, Kirillova et al. 1997). Also adenovirus mediated NF-κB inhibition 
during liver regeneration after partial hepatectomy resulted in increased liver 
apoptosis and dysregulation of cell cycle progression (Iimuro, Nishiura et al. 1998) 
suggesting a role of NF-κB in protecting the liver from TNF induced apoptosis (Beg 
and Baltimore 1996) during liver regeneration.  
NF-κB comprises a family of transcription factors (Annexe 1) which are kept in 
the cytoplasm by binding to its inhibitor IκB. NF-κB can be activated by two distinct 
mechanisms: the classical pathway and the alternative pathway. Most of our current 
knowledge relies on the classical pathway. This pathway is triggered by bacterial and 
viral infections, as well as pro-inflammatory cytokines, all of which activate the IKK 
complex. The IKK complex consists of two catalytic subunits with kinase activity; 
IKK1 (IKKα) and IKK2 (IKKβ) and a third regulatory subunit, IKKγ also called Nemo.  
The IKK complex phosphorylates IκBs (inhibitors of NF-κB) thereby targeting 
them for proteasomal degradation and liberating NF-κB dimers that are composed of 
either REL-A (also known as p65), c-REL or p50 subunits to enter the nucleus and 
mediate transcription of target genes (Hayden and Ghosh 2004) (Annexe 2).  
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Annexe 1. The NF-κB and IKK Protein Families 
Members of the NF-κB and IKK proteins are shown. The number of amino acids in each human 
protein is indicated on the right. Posttranslational modifications that influence IKK activity or 
transcriptional activation are indicated with P, U, or Ac for phosphorylation, ubiquitination, or 
acetylation, respectively. Inhibitory events and phosphorylation and ubiquitination sites on p100 and 
p105 proteins that mediate proteasomal degradation are indicated with red Ps and Us, respectively 
(Hayden and Ghosh 2008). RHD, Rel homology domain; TAD, transactivation domain; LZ, leucine 
zipper domain; GRR, glycine-rich region; HLH, helix-loop-helix domain; Z, zinc finger domain; CC1/2, 
coiled-coil domains; NBD, Nemo-binding domain; MOD/UBD, minimal oligomerization domain and 
ubiquitin-binding domain; and DD, death domain (Hayden and Ghosh 2008). 
 
 
Introduction 6 
  
Annexe 2. Crystallographic structure p50 (left) and p65/Rel A (right) 
 
This reaction mostly depends on the classical pathway involving IKK2, the 
subunit with the strongest catalytic activity, which phosphorylates IκB (Ghosh and 
Karin 2002) and Nemo, the regulatory subunit. The alternative NF-κB-activation 
pathway involves the upstream kinase NF-κB-inducing kinase (NIK) which activates 
IKK-α homodimers, independently of either IKK2 or Nemo leading to the 
phosphorylation and processing of p100, in response to certain members of the TNF 
family (Bonizzi and Karin 2004) (Hayden and Ghosh 2004). The two pathways switch 
on different gene sets and therefore mediate different immune functions (Bonizzi and 
Karin 2004). (Annexe 3) 
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Annexe 3. Signaling pathways that lead to the activation of different nuclear factor-B transcription 
factors and the biological consequences of these pathways. 
a. Two pathways can activate nuclear factor-κB (NF-κB). The classical pathway is triggered by pro-
inflammatory stimuli and genotoxic stress, including the following: cytokines, such as tumor-necrosis 
factor (TNF) and interleukin-1 (IL-1); bacterial cell-wall components, such as lipopolysaccharide; 
viruses; and DNA-damaging agents. This leads to the IKK-β (inhibitor of NF-κB (IκB) kinase-β)-
dependent and Nemo-dependent phosphorylation of IκBs, which results in their proteasomal 
degradation, and to the subsequent liberation of NF-κB dimers (which are mostly p50–REL-A dimers). 
The alternative pathway is triggered by certain TNF-family members and leads, in an IKK-β 
independent and Nemo-independent manner, to the phosphorylation of p100 by IKK-α and the 
degradation of its carboxy-terminal half by the proteasome. This results in nuclear translocation of 
p52–REL-B dimers.  
b. Activation of the classical pathway (which involves p50–REL-A dimers) leads to increased 
transcription of genes that can be divided into three functional classes, all of which contribute to tumor 
promotion and progression. BCL-XL, B-cell lymphoma XL; BFL1, a B-cell-lymphoma-2-related protein; 
cIAPs, cellular inhibitors of apoptosis; COX2, cyclooxygenase-2; GADD45β, growth arrest and DNA-
damage inducible 45β; iNOS, inducible nitric-oxide synthase; SOD2, superoxide dismutase 2. (Karin 
and Greten 2005). 
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The IKK complex subunits are not redundant. While IKK1 KO mice show limb 
and skeletal defects (Hu, Baud et al. 1999), IKK2 KO mice die embryonically due to 
massive liver apoptosis (Li, Chu et al. 1999). Nemo KO mice also die in utero 
although embryonic fibroblast from these mice exhibit a complete lack of NF-κB 
activation in response to TNF while MEFs from IKK2 slightly respond to the cytokine 
(Rudolph, Yeh et al. 2000). In this line of evidence our group has recently described 
striking differences, when these mice are challenged by different mechanisms of liver 
injury. While hepatocyte-specific IKK2 KO mice (IKK2Δhepa) show NF-κB activation 
and no liver damage after TNF injection (Luedde, Assmus et al. 2005), hepatocyte-
specific Nemo knockout mice (NemoΔhepa) present massive liver apoptosis and a 
complete lack of NF-κB activation (Beraza, Ludde et al. 2007). After 
Ischemia/reperfusion (I/R)-induced liver injury, IKK2Δhepa mice present less 
inflammation, apoptosis and necrosis compared to wildtype (WT) littermates which 
show high NF-kB activation that is significantly diminished in KO animals (Luedde, 
Assmus et al. 2005). In contrast, NemoΔhepa mice die shortly after I/R-injury due to 
massive liver apoptosis showing high non-parenchymal cells-dependent NF-κB and 
TNF activation even during the ischemic phase, which predisposes the liver to 
reperfusion-induced liver injury (Beraza, Ludde et al. 2007). 
 
During the past years, multiple studies with genetically modified animals have 
been performed in order to clarify the implication of different molecules and signaling 
pathways during liver regeneration (Yamada, Kirillova et al. 1997), (Hayashi, Nagaki 
et al. 2005), (Nakamura, Nonaka et al. 2004). However, deletion of a single gene 
frequently does not result in a complete inhibition of liver regeneration but can be 
linked to a dysregulation in cell cycle progression (Fausto, Campbell et al. 2006). 
This observation is probably best explained by the redundancy in signaling pathways 
between the different cytokines, growth or transcription factors activated during liver 
regeneration. However, since both TNF and NF-κB are key players during liver 
regeneration and based on the striking differences between IKK2Δhepa and NemoΔhepa 
KO mice, the current interest of this thesis is to use these mice to better define the 
mechanisms that are involved in activating NF-κB during liver regeneration after PH. 
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1.4. The cell cycle 
Regulation and precise control of the cell cycle is central to normal 
proliferation and differentiation. The cell cycle is divided in two events: mitosis and 
cytokinesis (Norbury and Nurse 1992). Replication of the DNA in each chromosome, 
followed by acurate separation is accomplished during M (mitotic) phase (nuclear 
division) of the cell cycle (Norbury and Nurse 1992). The interphase, situated 
between two M phases, is divided into three phases of the cell cycle: during S phase 
(S = synthesis) the nuclear DNA is replicated. The two remaining phases of the cell 
cycle occur between M and S phases and are designated as gap phases and 
constitute checkpoints for the cell (Jacobs 1992). The interval between the 
completion of M phase and beginning of S phase is G1 phase (G = gap), while G2 
phase is the interval between end of S phase and beginning of the M phase. 
Checkpoints of the cell cycle are in late G1 phase (restriction point), at the end of G2 
phase (G2/M checkpoint) or during mitosis (mitotic spindle checkpoint). Gaps during 
the interphase are fronting long-term mitotic inactivation of the cell during the G0 
phase (Lea, Orr et al. 2003),(Cooper 2003). Transition through cell cycle is tightly 
controlled by a number of cellular proteins, called Cyclin-dependent kinases (Cdks). 
They are regulated by their regulatory subunits termed Cyclins and Cdk inhibitors. 
Typically, protein levels of Cyclins peak during cell cycle in a cyclic manner. The 
process of DNA synthesis is initiated and regulated by four families of regulatory 
Cyclins (Cyclin D, E, A and B) combined with a limited number of Cdks (Cdk4/6, 
Cdk2 and Cdk1). The D family of Cyclins transduces mitogenic signals through their 
activation of Cdk4 and Cdk6 allowing activation of the next two complexes (Draetta 
1994; Sherr 1994; Kato 1999), through synthesis of Cyclin E1, E2 and Cyclin A. The 
E type Cyclins bind to Cdk2 and initiate DNA replication (Draetta 1994) (Reed, 
Wittenberg et al. 1991; Dulic, Lees et al. 1992; Lees, Faha et al. 1992). Cyclin A also 
binds to Cdk2 and is important for progression through S phase though they also 
bind Cdk1 in the later S phase and during G2 phase (Murphy, Stinnakre et al. 1997), 
(Liu, Lucibello et al. 1998). Finally, entrance into mitosis involves activation of Cdk1 
by the Cyclin B family members 
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Annexe 4. Schematic representation of cell cycle control.  
Progression through the mitotic cycle involves the successive formation, activation and subsequent 
inactivation of Cyclin-dependent protein kinases (Cdks). The kinases bind sequentially to a series of 
Cyclins, which are responsible for differential activation of the kinase during the cell cycle. The G1 to S 
transition is thought to be controlled by Cdks containing D-type Cyclins that phosphorylate the 
retinoblastoma protein, releasing E2F transcription factors. E2F are involved in the transcription of 
genes needed for the G1 to S transition. The G2 to M transition is controlled by Cdk complexes 
containing A and B Cyclins. Cdk complexes are kept in inactive state by phosphorylation by the Wee1 
kinase, and by interaction with inhibiting proteins (CKIs) (Andrietta, Eloy et al. 2001). 
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1.5. Involvement of the innate immune response during liver 
regeneration 
Activation of the innate immune system through TLR and other pattern-
recognition molecules (PRRs) play a key role in host defence against invading 
pathogens (Akira, Uematsu et al. 2006). Recent studies have highlighted the crucial 
contribution of these mechanisms to the inflammatory response after PH (Strey, 
Markiewski et al. 2003; Seki, Tsutsui et al. 2005; Campbell, Riehle et al. 2006). 
During the priming phase of liver regeneration, Kupffer cells get activated and secrete 
pro-inflammatory cytokines, most prominently Tumour Necrosis Factor alpha (TNF), 
Interleukin-6 (IL-6) and Interleukin-1 beta (IL-1β) which can initiate the Acute Phase 
Response (APR) in hepatocytes (Trautwein, Boker et al. 1994; Gabay and Kushner 
1999; Fausto, Campbell et al. 2006). Serum Amyloid A (SAA), C-reactive protein and 
the complement system are proteins involved in this physiological response to 
restore liver homeostasis (Trautwein, Boker et al. 1994; Gabay and Kushner 1999; 
Yoo and Desiderio 2003). Pro-inflammatory cytokine secretion from Kupffer cells 
during liver injury requires NF-κB activation and triggers a cascade leading to influx of 
inflammatory cells (Schwabe, Seki et al. 2006).  
LPS, IL-1β or TNF can induce production of chemotactic cytokines (chemokines) 
such as Chemokine (C-X-C motif) ligand 1 (CXCL-1, GRO1, or KC). These 
chemokines belong to the ELR+ CXC family which differ from ELR- CXC chemokines 
both structurally, due to the presence of 3-aa sequence (Glu-Leu-Arg; ELR) and 
functionally, as they can exert antagonistic effects (Charo and Ransohoff 2006). 
ELR+ CXC chemokines contribute to wound healing and resolution of inflammatory 
events by stimulating polymorphonuclear cell (PMN) recruitment to the site of injury 
(Charo and Ransohoff 2006). Furthermore, they have protective and pro-regenerative 
properties as shown during acetaminophen-induced liver injury (Hogaboam, Bone-
Larson et al. 1999). 
 
1.6. Reactive Oxygen Species 
 ROS are chemically reactive molecules that have essential biological 
functions. They regulate many signal transduction pathways by directly reacting and 
modifying the structure of proteins, transcription factors and genes to modulate their 
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functions. ROS are involved in signaling cell growth and differentiation, regulating the 
activity of enzymes (such as ribonucleotide reductase), mediating inflammation by 
stimulating cytokine production, and eliminating pathogens and foreign particles. A 
moderate increase in ROS can promote cell proliferation and differentiation (Balaban, 
Nemoto et al. 2005; Nishikawa 2008). In contrary, excessive amounts of ROS can 
cause oxidative damage to lipids, proteins and DNA because oxygen free radicals 
are highly reactive with biological molecules. The free radical reaction could cause 
oxidative modification of these biomolecules and alter their functions. A mild increase 
in the level of ROS may result in transient cellular alteration, whereas a severe 
increase of ROS in cells causes irreversible oxidative damage, leading to cell death. 
Therefore, maintaining ROS homeostasis is crucial for normal cell growth and 
survival. Cells control ROS levels by balancing ROS generation with their elimination 
by ROS-scavenging systems such as superoxide dismutases (SOD1, SOD2 and 
SOD3), glutathione peroxidase, peroxiredoxins, glutaredoxin, thioredoxin and 
catalase. An increase in ROS reflects a disruption of redox homeostasis due to either 
an elevation of ROS production or to a decline of ROS-scavenging capacity, a 
condition known as oxidative stress. 
ROS can be found either in the environment, for example, as pollutants, 
tobacco smoke, iron salts and radiation, or it can be generated inside cells. Cells 
produce ROS through multiple mechanisms. A major source of ROS is produced in 
the mitochondria. Electron leakage from the mitochondrial respiratory chain may 
react with molecular oxygen, resulting in the formation of superoxide, which can 
subsequently be converted to other ROS. In phagocytes and some cancer cells, ROS 
can be produced through a reaction catalysed by NADPH oxidase complexes. ROS 
can also be produced as a byproduct of certain biochemical reactions, such as β-
oxidation in peroxisomes, prostaglandin synthesis and detoxification reactions by 
cytochrome P450. 
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Annexe 5. Schematic illustration of cellular redox homeostasis. 
Major sites of cellular reactive oxygen species (ROS) generation (indicated in red) include the 
mitochondrial electron transport chain (Mito-ETC), the endoplasmic reticulum (ER) system and the 
NADPH oxidase (NOX) complex. Superoxide (O2–) is the main initial free radical species, which can be 
converted to other reactive species. In the mitochondria, superoxide is generated by the capture of 
electrons escaping from the electron transport chain by molecular oxygen. Superoxide can be rapidly 
converted to H2O2 by superoxide dismutases (SOD, yellow), which can be reused to generate 
superoxide radicals or converted to water by catalase. In the presence of transition metals (such as 
Fe2+), H2O2 can be converted to hydroxyl radicals (HO•), which are highly reactive and can cause 
damage to lipids, proteins and DNA. Nitric oxide (NO•) is a reactive radical produced from arginine by 
nitric oxide synthase (NOS). Nitric oxide has a very short half-life and can react with superoxide to 
form peroxynitrite (ONOO–), a non-radical species that is capable of modifying the structure and 
function of proteins. To prevent the harmful effects of ROS, cells regulate ROS levels by maintaining 
the balance between ROS generation and elimination  Major ROS-scavenging enzymes are shown in 
green. GPX, glutathione peroxidase; GR, glutathione reductase; GRXo, glutaredoxin (oxidized); GRXr, 
glutaredoxin (reduced); GSHr, glutathione (reduced); GSSG, glutathione (oxidized); TRXo, thioredoxin 
(oxidized); TRXr, thioredoxin (reduced); XO, xanthine oxidase. (Trachootham, Alexandre et al. 2009). 
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1.7. Knockout technology and transgenic mice  
Since beginning of the 20th century mice are used in experimental animal 
models due to their high reproduction rate, easy generation and relatively cheap and 
easy breeding. Thus the species of mice became one of the physiologically and 
genetically most intensively studied mammalian. This extensive knowledge of murine 
genetic and physiology established a basis for genetic manipulation of mice like the 
embryonic stem (ES) cell system. Genetic changes introduced into ES cells in tissue 
culture can be transferred into living mice (Gossler, Doetschman et al. 1986; 
Robertson, Bradley et al. 1986; Hooper, Hardy et al. 1987), breeding the chimeras 
and screening offspring for the ES genotype.  
Although knockout technology in mice is highly advantageous, it can also 
contain limitations. Due to developmental defects, many knockout mice die during 
embryogenesis or shortly after birth. In this case conditional knockout mice provide 
the opportunity of gene deletion on demand, allowing for cell or tissue-specific gene 
targeting as well as inactivation in a particular stage of development (Gu, Marth et al. 
1994).  
The most widely used method to generate conditional knockout models is the 
Cre-loxP recombinase system employing the DNA sequences and enzymes used by 
bacteriophage P1 to excise itself from a host cell’s genome (Austin, Ziese et al. 1981; 
Hoess, Ziese et al. 1982; Hamilton and Abremski 1984). As a typical recombinase, 
Cre (“Causes REcombination”) deletes the DNA fragment located between two 
recognition sites, e.g. the loxP sites (Voziyanov, Pathania et al. 1999). Regulated by 
definite promotors the activation of the Cre recombinase and thus the excision of the 
particular gene is controlled during a specific developmental stage, like in 
hepatocytes (AlfpCre promoter) (Kellendonk, Opherk et al. 2000) or when induced 
exogenously by interferon or pIpC (Poly-Inosin-Poly-Cytidilin) injection (Mx promoter) 
(Kuhn, Schwenk et al. 1995).  
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Annexe 6: Structure of the AlfpCre transgene. The Cre recombinase is expressed under the control of 
the mouse albumin enhancer and promoter and the three mouse alpha-fetoprotein enhancers (filled 
boxes). To ensure correct polyadenylation of the Cre mRNA, a 2.1 kb fragment of the human growth 
hormone gene (Behringer, Mathews et al. 1988) 
 
has been cloned downstream of the Cre open 
reading frame (ORF). Transgenic mice are generated by injecting FVB/N oocytes (inbred mice strain; 
commonly used for transgenic injection) with the NotI fragment of the Alfp-Cre DNA construct. 
Adopted from Kellendonk et al. (Kellendonk, Opherk et al. 2000).  
The hepatocyte-specific Cre transgenic mouse strain has been described 
earlier by Kellendonk et al (Kellendonk, Opherk et al. 2000) and contains a Cre 
recombinase under the control of AlfpCre promoter (Annexe 6). Including the three 
mouse AFP enhancers, the AlfpCre transgene becomes active at day 13,5 p.c.  and 
is highly efficient and selective for hepatocytes (Kellendonk, Opherk et al. 2000)
 
.  
 
1.7.1.  Generation of conditional IKK2 knockout mice 
I-Kappa-B-Kinase-Beta or IKK2 is a 757 AA cytoplasmic protein, weighing 
approximately 87 kDa (86,690 Da) and is located on chromosome 8p11.2. Disruption 
of the IKK2 gene in mice is lethal. Constitutive IKK2-/- mice (meaning that all the cells 
of the animal are deleted) die between embryonic day 12.5 and 14 due to extensive 
liver damage from apoptosis. But these mice can be rescued by inactivation of the 
TNFR1 gene, suggesting a role of TNF-α mediated apoptosis (Li, Van Antwerp et al. 
1999). Therefore, to study the role of IKK2 in adult tissue, a conditional IKK2 mouse 
was generated. Conditional IKK2 KO mice were viable due to the IKK2 deletion 
occuring in the late development and in a single cell population only, the hepatocytes 
in our case. Mice carrying loxP-site-flanked (floxed(f)) IKK2 gene (IKK2f/f) are 
described in Annexe 7 (Pasparakis, Courtois et al. 2002). IKK2f/f mice were crossed 
with AlfpCre transgenic mice which have the Cre recombinase under control of an 
Albumin promoter, (Kellendonk, Opherk et al. 2000). Crossings rendered Cre positive 
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(IKK2Δhepa) with exon 6 and 7 missing, leading to a null allele (Annexe 8), and Cre 
negative (IKK2f/f) mice that have a fully functional IKK2 protein (Pasparakis, Courtois 
et al. 2002) (Luedde, Assmus et al. 2005).  
 
Annexe 7. Conditional IKK2 knockout strategy. (Pasparakis, Courtois et al. 2002). 
 
 
Annexe 8. Cre recombinase under the control of an albumin promoter results in deletion of exon 6 and 
7 in the IKK2 floxed alleles. (Assmuss and Trautwein 2002). 
1.7.2.  Generation of conditional Nemo knockout mice 
Nemo is a 412 AA, weighing approximately 48kDa (47,942 Da). The genomic 
sequence is located on chromosome Xq28. Generation of Nemo/IKKγ-deficient mice 
by gene targeting lead to embryonical lethality. Mutant embryos die at E12.5–E13.0 
from severe liver damage due to apoptosis (Rudolph, Yeh et al. 2000). Hence 
conditional Nemo KO were generated (Schmidt-Supprian, Bloch et al. 2000; 
Pasparakis, Schmidt-Supprian et al. 2002). Conditional Nemo KO mice were viable 
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due to the Nemo deletion occuring in the late development and in a single cell 
population only, the hepatocytes in our case. Mice carrying loxP-site-flanked 
(floxed(f)) Nemo gene (Nemof/f) are described in Annexe 9 (Beraza, Malato et al. 
2009) Nemof/f mice were crossed with AlfpCre transgenic mice which have the Cre 
recombinase under control of an Albumin promoter (Kellendonk, Opherk et al. 2000). 
Crossings rendered Cre positive (NemoΔhepa) with exon 2 missing, leading to a null 
allele and Cre negative (Nemof/f) mice that have a fully functional Nemo protein 
(Luedde, Assmus et al. 2005; Luedde, Beraza et al. 2007; Beraza, Malato et al. 
2009).  
 
Annexe 9. Conditionnal Nemo knockout strategy. For the generation of conditional NEMO KO mice, 
we designed a gene-targeting vector containing two loxP sites in tandem orientation separated by a 
unique SalI restriction site and the neomycin resistance gene (neo) under the control of the cmv 
promoter flanked by FRT recombination sites. Gene-targeting strategy. Exons and introns are 
represented by vertical bars and horizontal lines, respectively. A neomycin-resistance gene driven by 
a cmv promoter (NEO) was used as selection marker. The exons are labeled by roman numbers. B, 
BamHI; S, SalI; X, XhoI (Rodriguez, Buchholz et al. 2000). 
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Annexe 10. Cre recombinase under the control of an albumin promoter results in deletion of exon 2 in 
the Nemo floxed alleles. (Assmuss and Trautwein 2004). 
 
1.8. Aim of the study 
The aim of the current project was to better characterize the role of NF-
κB during liver regeneration. 
This PhD work has been motivated by the apparent controversy described by 
different groups on the role of NF-κB during liver regeneration. Iimuro et al (Iimuro, 
Nishiura et al. 1998) completely inhibited NF-κB during liver regeneration using an 
adenoviral IκB superrepressor. This led to apoptosis and impaired hepatocyte 
proliferation after PH. Some years later Chaisson et al (Chaisson, Brooling et al. 
2002), used a transgenic mouse system which inducibly expressed a dominant 
negative IκB in hepatocytes. This model showed no significant effects on liver 
regeneration. 
Both models have their drawbacks, the use of adenoviruses is not harmless 
for the cells and apoptosis was observed before partial hepatectomy. The IκB super 
repressor system blocked NF-κB in 50% of hepatocytes only. This number is 
insufficient to assess any relevant biological role for NF-κB during liver regeneration. 
With the advance of technology and especially the development of conditional 
knockout and transgenic mice, this question can be better and more specifically 
addressed and therefore was the goal of the present work. 
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2. Material and Methods 
2.1.  Chemicals 
 
Name of the product        Company 
Ammoniumpersulfate (APS)       AppliChem 
Acetone          J.T.Baker 
Agarose          Invitrogen 
Acetic acid (glacial) 100%       AppliChem 
Ammoniumacetate         AppliChem 
Brij 35          Sigma 
Bromophenol Blue         Serva 
BSA (Bovine Serum Albumin)       Sigma 
Butylated hydroxyanisole       Sigma 
Calciumchloride (CaCl2)        Sigma 
Carboxymethylcellulose       Sigma 
Chloroform          Merck 
Cetyltrimethylammonium chloride      Sigma 
Collagen Type I from rat tail       Sigma 
Cremophor® EL        Sigma 
3,5-dicarbethoxy-1,4-dihydrocollidine (DDC)    Sigma 
Diethyl pyrocarbonate (DEPC)       Sigma 
Diethylether          J.T.Baker 
DTT (Dithiotreitol)         Sigma 
EDTA (N,N;N’,N’-Ethylendiamine-tetraacetate)    Calbiochem 
EGTA (Ethylen glycol-bis (2-aminoethyl)- N,N;N’,N’- tetraacetate)  Fluka 
Entellan          J.T.Baker 
Eosine          Sigma 
Ethanol, denaturated 100%       J.T.Baker 
Ethidiumbromide (EtBr) (Stock 10 mg/ml)     Sigma 
Formamide          AppliChem 
Formaldehyde 37%        Roth 
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Name of the product        Company 
Gelatin type B         Sigma 
Glucose          Merck 
Glutaraldehyde         AppliChem 
Glycerol (plant)         Serva 
Glycine          AppliChem 
Hämosin          Merck 
Hydrochloric acid (HCl)        AppliChem 
HEPES (2-[4-2-hydroxyethyl-1-piperazinyl]-ethansulfon acid) Merck 
Sulfuric acid (H2SO4)        Merck 
Lipopolysaccharide (LPS; E.coli O55:B5)     Sigma 
Magnesium chloride (MgCl2)       Sigma 
β-Mercaptoethanol         AppliChem 
Methanol          J.T.Baker 
MOPS (3-[N-Morpholino] propanesulfonic acid)    Sigma 
Nonidet P – 40         Sigma 
Paraformaldehyde         Merck 
PBS (Phosphate buffered saline)      Biochrom 
Phenethyl isothiocyanate (PEITC)     Sigma 
Phenylmethyl sulfonyl fluoride (PMSF)      Roth 
Ponceau Red         Sigma 
Potassium chloride (KCl)        Merck 
2-Propanol          Merck 
Salicylic acid         Sigma 
Sodium carbonate (Na2CO3)       Merck 
Sodium hydrogencarbonate (NaHCO3)      Merck 
Tri-sodium citrate 2-hydrate       Roth 
SDS (Dodecylsulfate)        Roth 
Sodium fluoride (NaF)        Roth 
di-Sodiumhydrogenphosphate 2-hydrate (NaH2PO4)    Roth 
Sodium vanadate (Na3VO4)       Sigma 
TEMED (N,N,N’,N’-Tetramethylethylendiamine)    Sigma 
3,3-5,5-tetramethyl-benzidine       Sigma 
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Name of the product        Company 
Tris-(hydroxymethyl)-propane-1,3-diol      AppliChem 
Triacetic acid         Merck 
Triton X-100          Sigma 
Trypan blue stain 0,4%        Gibco 
TWEEN-20          Sigma 
Xylene          J.T.Baker 
 
2.1.1. Radiochemicals 
 
[32P]-γ-ATP (10mCi/ml)        Hartmann Analytic 
 
2.2. Instruments and equipment 
Botting Trans-BlotTM Cell        BioRad 
Cell culture centrifuge Megafuge 1.0R      Heraeus 
Cell culture flow         Gelaire 
Cell culture Incubator        Heraeus 
Centrifuge 5415D         Eppendorf 
Cooling centrifuge 5417R        Eppendorf 
Cryostat HM 550         Microm 
ELISA Reader μQuant        BIO-TEK 
+KC4 Software 
FACS Canto II analyzer       Beckton Dickinson 
+BD FACSDiva software 
Gel dryer          Biometra 
LAS-4000 Mini Imager       Fujifilm  
Liquid scintillation counter 1219 Rack Beta LKB    Wallac 
Overhead shaker REAX 2       Heidolph 
Perfusion pump         Ismatec 
pH Meter PB-11         Sartorius 
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Name of the product        Company 
Powersupply PowerPac HC       BioRad 
7300 Real-Time PCR System       Applied Biosystems 
+ Sequence Detection Software Version 1.3.1.  
Roller Mixer SRT 9         Stuart 
Rotating incubator         Bachofer 
SDS PAGE electrophoresis system PerfectBlue Twin L   Peqlab 
Shaking incubator Unimax 1010       Heidolph 
Thermocycler T3000 and Tpersonal      Biometra 
Thermomixer 5436         Eppendorf 
Water bath Haake W13        Fisons 
Weighing machines        Sartorius 
 
2.3. Consumables 
2.3.1. General material 
Nitrocellulose membrane Protran ®      Whatman 
Scintillation tubes Pony vialTM       Packard 
Scintillation fluid Ultima GoldTM XR      Packard 
Super Frost slides         Roth 
X ray films          Amersham 
 
2.3.2. Material for animal experimentation 
Catheter with injection port (Biovalve® 20G; 1,0x32mm)   Vygon 
Disposable Scalpels sterile No. 10, 11      Feather 
Ethibond® Excel plated, laminatet, not absorbable; 6/0 metric 0,7  Ethicon 
General chow for rodents        Altromin 
BHA 0.7% supplemented diet      Ssniff 
DDC 0.1% supplemented diet      Altromin 
Hematocrit capillary        Brand 
Heparine (Liquemin®)        Roche 
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Name of the product        Company 
Injection needles (Sterican®; Gr.17 24Gx25mm; 0,4x12mm)  Braun 
Isofluran (Forene®)         Abbott 
Ketamin (Ketamin®)        Albrecht 
Micro tube (1,1 ml Z-Gel)        Sarstedt 
Sterile gossamer (Sterilkompresse®)      Beese 
Surgical instruments        F.S.T 
Syringe Omnican®         Braun 
Syringe Discardit II (2, 5, 10, 20 ml)     Beckton Dickinson 
Vicryl®, absorbable 4-0        Ethicon 
Xylazin (Rompun®)         Bayer 
 
2.3.3. Material for cell culture and flow cytometry  
Cell strainer with 70 µm nylon mesh      
Cell scrapers         Costar 
Cell culture plates (6 well)       Costar 
DMEM  +4500mg/L Glucose      Gibco 
+GlutaMAX 
+Pyruvate 
Fetal Calf Serum (FCS)        PAA 
10x PBS pH 7,4         Gibco 
Penicillin/Streptomycin (P/S)       Gibco 
EBSS negative        Gibco 
EBSS positive        Gibco 
Hanks  Buffer Saline Solution      PAA 
RPMI          PAA 
LS column         Miltenyi Biotec 
 
2.3.4. ELISA and MACS kits 
mouse IL-6 ELISA        R&D Systems 
mouse TNFα  ELISA       R&D Systems 
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mouse Sca1 FITC + anti-FITC Microbeads    Miltenyi Biotec 
 
2.3.5. Antibodies 
2.3.5.1. Non-labeled primary antibodies 
Reference         Specy 
anti-Cyclin A (C19; sc-596; Santa Cruz)     Rabbit 
anti-Cyclin D1 (72-13G; sc-450; Santa Cruz)    Mouse 
anti-p65 (A; sc-109; Santa Cruz)      Rabbit 
anti-F4/80 (MCAP497; Serotec)      Rat 
anti-Cd68 (MCA195TGA; Serotec)     Rat 
anti-GAPDH (4699-9555; Biogenesis; discontinued)   Mouse 
anti-p-STAT-3 (Tyr705; #9131s; Cell Signaling)   Rabbit 
anti-CK19 (M-17; sc-33111; Santa Cruz)    Goat 
anti-CK19 (Troma 3 Developmental Studies, Hybridoma Bank) Rat 
anti-Ki67 (M-19; sc-7846; Santa Cruz)     Goat 
anti-Ki67 (Dianova, discontinued)     Rabbit 
anti-HNF4α (C-19 ; sc-6556 ; Santa Cruz)    Goat 
anti-p21 (C-19 ; sc-397 ; Santa Cruz)     Rabbit 
anti-NOS2 (M-19 ; sc-650 ; Santa Cruz)     Rabbit 
anti-IKKγ (FL-419 ; sc-8330 ; Santa Cruz)    Rabbit 
anti-pJNK1/2 (44-682G ; Invitrogen)     Rabbit 
anti-JNK1 (sc-571; Santa Cruz)      Rabbit 
anti-BrdU (RPN20, GE healthcare)     Mouse 
anti-pHistone H3 (Thr 11; #9764s Cell Signaling)   Rabbit 
anti-pH2A.X (Ser 139; #9718s; Cell Signaling)    Rabbit 
anti-Tubulin (sc-58666 ; Santa Cruz)     Mouse 
anti Actin (A2066; Sigma)       Rabbit 
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2.3.5.2. Labeled primary antibodies 
Reference         Fluorochrome 
anti-CD45 (e-Bioscience)       APC-CY7 
anti-CD11b (e-Bioscience)      PE 
anti-F4/80 (Serotec)       Biotinylated 
anti-LY6G (e-Bioscience)        FITC 
anti-NK1.1 (e-Bioscience)       PE 
anti-CD4 (e-Bioscience)        APC 
anti-CD8 (e-Bioscience)        FITC 
anti-Sca1 (BD Bioscience)       PE-CY7 
anti-cKit (BD Bioscience)       PE 
 
2.3.5.3. Secondary antibodies 
HRP-linked goat anti-mouse immunoglobulin G (sc-2005; Santa Cruz) 
HRP-linked anti-rabbit immunoglobulin G (#7074; Cell Signaling) 
HRP-linked donkey anti-goat immunoglobulin G (705-035-147; Jackson Research) 
HRP-linked mouse anti-rat immunoglobulin G (212-035-168; Jackson Research) 
 
2.3.6. Enzymes 
Name of the product        Company 
DNA Taq Polymerase (5U/μl) (+10x PCR-MgCl2 buffer)   Invitrogen 
M-MLV (200U/μl)         Invitrogen 
Proteinase K         AppliChem 
SYBR® GreenER qPCR SuperMix      Invitrogen 
Collagenase Type II       Worthington 
Collagenase Type IV       Worthington 
Trypsin inhibitor        Sigma 
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2.4. Analytical chemicals, reagents and kits 
Name of the product        Company 
30% Acrylamide/Bis Solution, 37,5:1 (2,6%C)     Biorad 
ATP (Adenosintriphospate; 10mM; for Kinase Assay)   Invitrogen 
Block & Sample 5X Buffer       Promega 
Biorad reagent®         Biorad 
Cell Proliferation (BrdU) Kit®BrdU      GE Healthcare 
Complete Mini® (Proteinase Inhibitor Cocktail)     Roche 
Coomassie-Brilliant-Blue®        Roth 
Covering solution for cryo sections (Tissue-Tek®)    Sakura 
Diaminobenzidine (DAB)        Sigma 
DNA marker 1kbplus Ladder®       Invitrogen 
DNA Taq Polymerase (5U/μl)       Invitrogen 
EDTA (25mM)        Invitrogen 
HotStarTaq Master Mix Kit      Qiagen 
MgCl2 (50mM; for PCR)        Invitrogen 
Mounting Medium® VectaShield      Vector 
Novex® Sharp Pre-stained Protein Standard    Invitrogen 
peqGOLD-RNAPure®        Peqlab 
Protein A agarose beads        Santa Cruz 
Roti®-Block 10X        Roth 
Random Primers (3μg/μl)        Invitrogen 
RNase OUT® Ribonuclease Inhibitor (40U/μl)     Invitrogen 
Super Signal West Pico       Pierce 
Tetramethylbenzidine substrate (TMB)      Sigma 
TUNEL kit fluorescein       Roche 
(Terminal deoxynucleotidyl transferase dUTP Nick End Labeling) 
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2.5. Animals 
2.5.1. Animal breeding 
Animals were bred under standardized conditions following National Academy of Sciences 
(NIH publication 86-23 revised 1985) criteria in the “Institut für Versuchstierkunde” of the 
University Hospital of the RWTH Aachen (UK Aachen). During breeding and the 
subsequent experiments a 12 hours light-dark rhythm, standardized temperature of 20-
24°C and humidity of 50-60% was maintained by central air conditioning. Mice were housed 
in macrolon cages providing food and water ad libitum and were grouped up to 10 animals 
per cage. Biopsies of tail tips for genotyping were taken after earmarking and separation of 
the litter mates from the breeding couples. All studies were approved by the appropriate 
authorities according to the german legal requirements.  
 
2.5.2. Partial hepatectomy 
Pathogen-free 7 to 9 week old male mice were used for partial hepatectomy (PH). Liver 
surgeries (Higgins 1931) were performed under ketamin/xylazine anesthesia and adapted 
to mouse physiology. Carprofen (5mg/kg bodymass) was used as analgesia for 3 days 
every 12 hours post hepatectomy. 
Each time point provides at least 5 mice per genotype. Remaining livers were removed, 
rinsed in ice-cold PBS and individually frozen in liquid nitrogen and Tissue Tek (Sakura 
Europe). 
 
2.5.3. Blood taking 
Retro-orbital sampling was performed in mice under transient anaesthesia using Isoflurane 
by penetrating the retro-orbital sinus with a glass capillary. Blood samples were collected in 
a serum tube, left 30 min at room temperature then centrifuged at 12000 rpm for 5 minutes 
at room temperature. Serum was transferred into a fresh tube and stored at -20°C. 
 
2.5.4. Systemic IKK2 inhibition 
To inhibit IKK2 in all cell compartments, 10 µg/g body weight of the specific pharmaceutical 
IKK2 inhibitor AS60286817 were administrated (kindly provided by Merck-Serono 
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International SA) or vehicle (0.5% carboxymethylcellulose/Tween 20 0.25%). Treatment 
was given orally 24 hours and 1 hour before PH, and the dose was repeated 24 hours after 
liver resection. 
 
2.5.5. Oval cell expansion (DDC diet) 
For DDC experiments 7-8 weeks old male mice were fed ad libitum with standard chow 
containing 0.1% of 3,5-dicarbethoxy-1,4-dihydrocollidine (DDC) and normal drinking water. 
 
2.5.6. Antioxidant treatment (BHA diet) 
4-5 weeks old male mice were fed ad libitum with a standard chow containing 0.7% of 
Butylated Hydroxyanisole (BHA) and normal drinking water. 
 
2.5.7. Oxidative stress induction (PEITC injection) 
7 weeks old mice were injected daily for one week via intraperitoneal injection with 50 
mg/kg of Phenetyl Isothiocyanate (PEITC) in a vehicle containing Ethanol/Cremophor 
EL/PBS in a ratio 1/1/8. Vehicle injection did not lead to any difference in the phenotype of 
the mice before or after partial hepatectomy, therefore only the chow diet results are shown 
as a control. 
 
2.5.8. Isolation of primary hepatocytes 
Cells taken directly from the living organism known as primary cell culture can keep the 
differentiated state for a short period (days to weeks). In the present project primary mouse 
hepatocytes from transgenic mice were isolated by collagenase perfusion. Mouse livers 
were perfused with a Krebs Ringer buffer in retrograde fashion followed by perfusion with a 
collagenase solution. Therefore mice were i.p. sedated and anaesthetized with 
Ketamin/Xylazin depending on the body weight (100 mg/kg Ketamin combined with 10 
mg/kg Xylazin) and anticoagulated with 50 μl of low molecular heparine. After fixation of the 
sedated animal in supine position the abdominal cavity was opened with a caudocranial cut 
in the Linea alba. Subsequently the Vena portae is laid open and an intravenous catheter 
(Biovalve 20G) was applicated. After opening the Vena cava caudalis, a perfusion with 50 
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ml of EBSS negative buffer including  250 µl EGTA 100 mM pH 8.3 (0,38 g for 10 ml) was 
performed with a flow rate of 2 ml/min until the hepatic vascular system was clarified from 
blood. Immediately the perfusion was continued with 30 ml of EBSS positive buffer 
completed with 5 ml Hepes pH 7.4 in 500 ml (10 mM final). Ultimately, 50 ml of complete 
EBSS positive buffer containing 30 mg of Collagenase type II (50 mg for Nemo) + 2 mg 
Trypsin inhibitor was perfused. As soon as the structure of liver tissue was abrogated, 
perfusion was stopped and the organ was withdrawn. Accordingly, the following procedure 
was carried out under sterile conditions. The capsule of the liver was opened in ice cold 
DMEM medium for release of the separated hepatocytes. The suspension was then filtered 
through sterile gossamer and centrifuged at 300g at 4°C for 2 minutes to separate viable 
cells from tissue and cell residues. After discarding the supernatant the pellet was 
resuspended in fresh medium for another washing procedure. Finally cells were 
resuspended in DMEM medium containing 10% fetal calf serum (FCS), penicillin and 
streptomycin. Viability of hepatocytes was determined using a Neubauer counting chamber 
and were subsequently disseminated with a density of 8x105 cells per 6 cm well. The day 
before, plates were prepared and wells were coated with collagen. Adhesion and survival of 
cells was controlled after three hours and cells were washed intensely with sterile 1x PBS 
(3ml per well). 
 
2.5.9. Cell isolation and flow cytometry 
Single cell suspensions were yielded by mechanical enzymatic digestion of freshly isolated 
livers 12h after PH. Liver samples were minced with scissors and subsequently digested for 
30 min in 0.3225 U/ml Collagenase type IV in RPMI medium at 37°C. After digestion the 
extract was filtered twice through a 70 µm filter (Falcon, Becton Dickinson) with 20 ml of 
HBSS (Hanks Buffer Saline Solution) supplemented with 1% BSA and 2mM EDTA. The 
suspension was centrifuged at 300g for 10 min to remove cell conglomerates. The 
supernatant was transferred into 15 ml tubes and passed through a 30 µm filter (cellTrics, 
Partec), centrifuged 10 min at 1200g, washed twice in Hanks buffer completed with 1 ml of 
30% BSA and 1,5 ml of EDTA 0.5M pH 8.8 (Hanks complete) for 5 min at 1200g. Pellets 
were then transferred to Facs Tubes, and cells were stained for CD45, F4/80, Gr1 (Beckton 
Dickinson Biosciences) and CD11b (Serotec), as well as NK1.1 and CD3 (eBioscience) for 
45 min and subsequently analyzed by flow cytometry (Becton Dickinson FACS Canto II).  
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For analysis of blood leukocytes, blood was taken by puncture of the retro-orbital venous 
plexus. Red blood cell lysis was performed using 1X Pharmlyse buffer (Becton Dickinson, 
BD) following the manufacturer’s instructions. Leukocytes were then stained for CD11b, 
Gr1, CD19 (BD), CD115 and CD3 (eBioscience) and subjected to flow cytometric analysis. 
White blood cells were counted by an automat in the animal facility of the university and 
results were expressed in number of cells per µl. 
 
2.6. RNA isolation 
2.6.1. Isolation of RNA from liver tissue 
From deep frozen liver tissue around 50 mg was cut on dry ice and 2 ml of peqGOLD-
RNAPure® was added. After homogenization with a potter the lysate was incubated for 5 
minutes at room temperature. After adding 400 μl of chloroform under an extractor hood the 
sample was vortexed thoroughly for 15 seconds and again incubated at room temperature 
for 10 minutes. Due to centrifugation at 13000 x g for 5 minutes the lysate formed up three 
phases. The liquid upper phase beared the disassociated RNA, whereas the interphase 
and the lower phase contained impurities of DNA and protein. Avoiding any contact with the 
interphase, the upper phase was transferred carefully to a fresh reaction tube. After addition 
of 500 μl 2-propanol samples were incubated for 10 minutes at room temperature. 
Precipitated RNA was then isolated by centrifugation for 10 minutes at 13000 x g and 4°C. 
After discarding the supernatant the pellet was washed twice with 1 ml 70% ethanol. For 
washing, centrifugation was performed at 13000 x g at 4°C for 10 minutes. Subsequently, 
the pellet was dried for 5 minutes and in dependence of the dimension dissolved in 40-80 µl 
RNAse-free dH2O by incubation at 60°C. Storage of isolated RNA was performed at -80°C. 
 
2.6.2. Isolation of RNA from cell culture 
Plated primary hepatocytes were washed twice with 3 ml of sterile 1x PBS, after removal of 
cell culture medium. Then 1 ml peqGOLD-RNA Pure® was pipetted in each well of the 
commonly used 6-well-plate and scraping was performed using cell scrapers. Cell lysates 
were transferred to reaction tubes and treated like samples from liver tissue. 
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2.6.3. Determination of RNA concentration 
Purified RNA was diluted 1:50 in RNAse-free dH2O to measure optical density at 260 nm 
(OD260). Adjustment was done measuring dH2O. Calculation of RNA concentration based 
on the formular: 1OD260 = 40 µg RNA/ml. The purity of RNA was analyzed with additional 
determination of the extinction at 280 nm. The ratio of E260/E280 between 1,8 and 2,1 
accounts for pure RNA. 
 
2.6.4. Reverse Transcription (RT-PCR) 
Reverse transcription is a process in which single-stranded RNA is reverse transcribed into 
complementary DNA (cDNA). In combination with real time PCR this method is applied for 
profiling the expression of particular genes. The reaction is carried out using total cellular 
RNA, a reverse transcriptase enzyme, random primers, dNTPs and an RNase inhibitor. For 
a RT reaction, 3 μg of RNA was first incubated at 70°C to denature RNA secondary 
structure and was then quickly chilled on ice. Afterwards 38 μl of the reaction mix was 
applicated to each sample. RT reaction was then extended at 37°C for one hour. Finally, 
the enzyme was inactivated by incubation at 95°C for 5 minutes. All reagents were 
purchased from Invitrogen. 
 
Reaction Mix: 
10 μl 5x First Strand buffer 
2 μl DTT (0,1M) 
3 μl diluted (1:10) Random Primers at 3µg/µl  
5 μl dNTP Mix (1:10 dilution of 100mM dATP, dCTP, dGTP and dTTP) 
1,25 μl RNase Out (Ribonuclease Inhibitor (40 U/μl) 
15 μl DEPC-H2O 
1,75 μl M-MLV (200 U/μl) 
 
2.6.5. Real-Time PCR 
Real-Time PCR provides the opportunity of DNA amplification combined with analysis and 
quantification of the PCR product. Addition of a fluorescent dye like SYBR Green I enabled 
monitoring of PCR reactions in real time. This dye intercalates into double-stranded (ds-) 
DNA and produces a fluorescent signal, whose intensity is proportional to the amount of 
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dsDNA present in the reaction. Since DNA amplification during PCR appears to be 
logarithmic, at each step of the PCR reaction, the signal intensity increases as the amount 
of product increases. Especially in gene expression analysis quantitative Real-Time PCR is 
playing a decisive role. In order to measure gene expression by quantifying messenger 
RNA (mRNA) reverse transcriptase is needed to convert mRNA into complementary DNA 
(cDNA), which then can be amplified and analyzed by PCR. There are several methods to 
quantify alterations in mRNA levels using Real-Time PCR. Absolute quantification, 
calculating the amount of DNA molecules is performed by calibration with a standard curve. 
In the present studies an approximation method was used providing relative quantification. 
The ΔΔCt method was one of the first methods to be used to calculate real time PCR 
results (Applied Biosystems; User Bulletin #2: Relative Quantitation of Gene Expression 
(PN 4303859). This comparative method involves comparing the Ct values (threshold 
cycle), the fractional cycle number at which the fluorescence passes the fixed threshold. 
The Ct values of samples of interest are compared with a control or calibrator such as a 
non-treated sample or RNA from normal tissue. The Ct values of both the calibrator and the 
samples of interest are normalized to an appropriate endogenous housekeeping gene.  
[delta][delta]Ct = [delta]Ct,sample - [delta]Ct,reference 
Here, [delta]CT,sample is the Ct value for any sample normalized to the endogenous 
housekeeping gene and [delta]Ct,reference is the Ct value for the calibrator also normalized 
to the endogenous housekeeping gene. 
 
Reaction Mix: 
12,5 μl SYBR® GreenER qPCR SuperMix 
8 μl DEPC-H20 
1 μl sense primer (100μM) 
1 μl antisense primer(100μM) 
2,5 μl cDNA template    
25 μl final volume 
 
The following PCR program was used for all real-time primer pairs: 
 
 
Procedure   Temperature  Duration Step   Cycle 
1. Activation    50°C    2 min 
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2. Denaturation   95°C     10 min 
3. Denaturation   98°C     15 sec 
4. Annealing Tm*   59°C     30sec 
5. Elongation   59°C    30 sec   3      40 
6. Conservation   4°C     ∞ 
* Data collection 
The specificity of PCR products was confirmed by melting curves and electrophoresis. 
 
2.7. Isolation and characterization of proteins 
2.7.1. Protein extraction from liver tissue and primary hepatocytes 
Frozen liver tissue (~ 0,1 g) was homogenized on ice in 1 ml extraction buffer with a glass 
potter avoiding vigorous shear forces. Primary hepatocytes from cell culture were washed 
twice in PBS and 0,5 ml of extraction buffer was added to each well of a 6-well plate. 
Scraping of the cells leads to homogenization of the cells. For purification homogenates of 
both tissue and cell culture were centrifuged at 10.000 rpm for 10 minutes at 4°C. Protein 
concentration of the withdrawn supernatant was then determined by Bradford assay (see 
2.7.2.) and sample buffer was added subsequently to a concentration of 1 µg/µl. For 
denaturation samples were heated up to 95°C for 5 minutes, were loaded to a 
polyacrylamide gel or were snap-frozen in liquid nitrogen and stored at -80°C. 
1x Extraction buffer:   2x Sample buffer: 
1M NaCl      500mM Tris pH 6,8 
10mM EGTA     60% Glycerol 
500mM EDTA pH 8    25% SDS 
1M NaH2PO4     1% bromophenol blue 
1M Tris pH 7,5     200mM DTT 
1M NaF 
1% Triton X-100 
Freshly added: 
100mM PMSF (in Ethanol) 
1 Complete Mini® 
1mM Na3VO4 
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2.7.2. Quantification of proteins by Bradford Assay 
The Bradford method is a colorimetric method based on the binding of Coomassie brilliant 
blue to unknown protein. The measured absorbance of the unknown protein is then 
compared with a bovine serum albumin (BSA) standard also stained with Coomasie brilliant 
blue. The absorbance maximum of the Coomassie Brilliant Blue G-250 dye shifts when it 
binds to protein. The quantification of proteins in extracts was performed using the Bio-Rad 
reagents according to manufactures instruction. Different concentrations of BSA (1 mg/ml; 
2,5 mg/ml, 5 mg/ml; 7,5 mg/ml; 10 mg/ml; 15 mg/ml and 20 mg/ml) were used as 
standards. 2 μl of protein sample was added to 998 μl of the 1:5 diluted dye reagent, mixed 
briefly and incubated at room temperature for 10 min. The absorbance was measured at 
595 nm, which allowed calculation of protein concentration deduced from the standard BSA 
curve. 
 
2.7.3. c-Jun-N-terminal-Kinase activity assay  
c-Jun N-terminal kinase (JNK) activity was assessed as described in the literature 
(Westwick and Brenner 1995). As a substrate, we used a purified recombinant protein 
containing the N-terminal amino acids 1-223 of the human c-Jun fused to glutathion-S-
transferase. For immobilization, 15 µg recombinant glutathion-S-transferase-Jun protein 
was attached to glutathion agarose beads (Sigma) in buffer containing 1.0% Triton X-100 
and 1 mM dithiothreitol followed by incubation with 50 µg of total liver protein extract at 4°C 
overnight. After extensive washing in 20 mM [4-(2-hydroxyethyl)-1-piperazine 
ethanesulfonic acid] (pH 7.5); 20 mM MgCl2; 20 mM glycerophosphate; and 2 mM 
dithiothreitol, the bead-protein complexes were incubated with [32P]γ–adenosine 
triphosphate and 40 pM adenosine triphosphate for 20 minutes at 30°C. After kinase 
reaction, the proteins were fractionated on a 10% sodium dodecyl sulfate–polyacrylamide 
gel and visualized on X-ray film (Amersham). A single prominent band of 46 kDa 
represented phosphorylated glutathione-S-transferase-c-Jun. 
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2.7.4.  Zymography  
100 µg of whole liver proteins, extracted with the same buffer than the previous 
experiments, were subjected to electrophoresis in an 8% SDS-polyacrylamide-gel 
supplemented with 10mg/ml of Gelatinase A (Sigma). Loading buffer should not be 
denaturative (without DTT), samples are not boiled before loading. Then, gel was washed 
2x15 minutes in Triton 2.5% in a rocking surface. Next, the gel was incubated at 37 °C for 
24-48 hours in an incubation buffer. Gel was fixed and stained with 0.5% Coomassie blue in 
10% Acetic Acid, 30% Isopropanol and 60% Water. After destaining the gel, gelatinase 
digestion by MMP-9 activity was detected as a non-stained band. 
Incubation buffer       for 1L 
50mM TrisHCl, pH 7.4      6,06 g 
10mM CaCl2.2H2O       1,47 g 
100mM NaCl       5,84 g 
0.05% Brij 35       1,666 ml 
0,02% NaN3        200 mg 
 
2.8. Genotyping 
2.8.1. Buffer 
NID Buffer for tails: 
0,05M KCL  
0,01M Tris HCl pH 8.3 
0,002M MgCl2 
0,1 mg/ml Gelatin type B (type A also works) 
0,45% NP40 
0,45% Tween 20 
Complete with dH2O 
 
200 µl of NID buffer + 1 µl of Proteinase K was used for each tail and incubated overnight at 
56°C with mild shaking. Later on, the lysate was boiled 95°C for 10 minutes, spinned down 
shortly. Finally, the supernatant could be used for genotyping PCR. 
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2.8.2. PCR protocols and programs 
Cre PCR 
2,5 µl 10x Buffer without MgCl2 
0,75 µl MgCl2 
2 µl dNTP mix 
0,5 µl Cre 4 primer 
0,5 µl Cre 5 primer 
17,5 µl H2O 
0,25 µl Taq 
Mix 24 µl + 1 µl DNA 
 
Cre PCR program: 
Procedure    Temperature  Duration Step   Cycle 
Initial Denaturation    94°C     3 min 
Denaturation    94°C     15 sec 
Annealing Tm    53°C     30 sec 
Elongation     72°C    1 min    3    32 
Final Elongation   72°C    3 min 
Conservation    4°C     ∞ 
A single band of 1000 bp was detected using a 1% agarose gel containing Ethidium 
bromide 
 
IKK2 PCR 
2,5 µl 10x Buffer without MgCl2 
0,75 µl MgCl2 
2 µl dNTP mix 
0,5 µl MP65 IKK2 primer 
0,5 µl MP45 IKK2 primer 
17,5 µl H2O 
0,25 µl Taq 
Mix 24 µl + 1 µl DNA 
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IKK2 PCR program 
Procedure    Temperature  Duration Step   Cycle 
Initial Denaturation    94°C     3 min 
Denaturation    94°C     15 sec 
Annealing Tm    61°C     30 sec 
Elongation     72°C    30 sec    3    33 
Final Elongation   72°C    3 min 
Conservation    4°C     ∞ 
Two bands can be detected using the IKK2 primers, a fragment of 436 bp corresponding to 
wild type IKK2 allele and a fragment of 533 bp corresponding to the “floxed IKK2 allele” with 
two loxP sites flanking exons 6 and 7 (IKK2loxP/loxP or IKK2fl/fl).   
 
Nemo PCR 
9,5 µl H2O 
1 µl M27 Nemo primer 
1 µl Nemoloxscr primer 
12,5 µl HotStar Taq Mastermix 
Mix 24 µl + 1 µl DNA 
 
Nemo PCR program 
Procedure    Temperature  Duration Step   Cycle 
Initial Denaturation    94°C     3 min 
Denaturation    94°C     30 sec 
Annealing Tm    60°C     1 min 
Elongation     72°C    1 min    3    38 
Final Elongation   72°C    3 min 
Conservation    4°C     ∞ 
 
Two bands can be detected using the Nemo primers, a fragment of 432 bp corresponding 
to wild type Nemo allele and a fragment of 577 bp corresponding to the “floxed Nemo allele” 
with two loxP sites flanking exon 2 (NemoloxP/loxP or Nemofl/fl).   
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2.9. Primers list 
2.9.1. Genotyping primers (5’ -> 3’) 
cre4: cca cga cca agt gac agc aat 
cre5: ttc gga tca tca gct aca cca 
 
MP65 IKK2: gtt cag agg ttc agt cca tta tc 
MP45 IKK2: tag cct gca aga gac aat acg 
 
Nemo loxscr1: tat gtt tca cat cac atc gtt atc c 
Nemo - M 27: gcc ttg gtg ctc cct aac tct 
 
2.9.2. Real-Time PCR primers 
 
SAA2-135: tgg ctg gaa aga tgg aga caa 
SAA2-249: aaa gct ctc tct tgc atc act g 
 
CXCL1-119: ctg gga ttc acc tca aga aca tc 
CXCL1-235: cag ggt caa ggc aag cct c 
 
BRCA1-276: ttt tga gct tga cac ggg aat 
BRCA1-375: gat gat cga cgc ctc ctc att 
 
CK19-58: ggg ggt tca gta cgc att gg 
CK19-170: gag gac gag gtc acg aag c 
 
IL6Ra-870: gtt cca gct tcg ata ccg acc 
IL6Ra-985: gga cca cgt gct tca ctc c 
 
MyD88-546: aga aca gac aga cta tcg gct 
MyD88-653: cgg cga cac ctt ttc tca at 
 
gp130-483: atc aga gtg ggc aac aga gaa 
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gp130-621: tga gga gac ctt ccc aag gg 
 
jun-170: act cgg acc ttc tca cgt c 
jun-276: cgg tgt agt ggt gat gtg cc 
 
NOS2-103: gtt ctc agc cca aca ata caa ga 
NOS2-229: gtg gac ggg tcg atg tca c 
 
GAPDH-Anti: aac ctg cca agt atg atg aca tca 
GAPDH-Sense: tgt tga agt cac agg aga caa cct 
 
DR-5-772: gag gct gtg aac ggg atc c 
DR-5-929: gtc gtt tcc gtt tac cgg aac c 
 
SCA1-sense: agg agg cag cag tta ttg tgg 
SCA1-anti: cgt tga cct tag tac cca gga 
 
F4/80+Wag.Sense: ctt tgg cta tgg gct tcc agt c 
F4/80+Wag.AS: gca agg agg aca gag ttt atc gtg 
 
Myc-211: tct cca tcc tat gtt gcg gtc 
Myc-324: tcc aag taa ctc ggt cat cat ct 
 
TNFalpha-632: gcc gat ttg cta tct cat acc agg 
TNFalpha-752: ccc agg tat atg ggc tca tac c 
 
MnSOD-246: ccg agg aga agt acc acg agg 
MnSOD-383: cac cac cct tag ggc tca gg 
 
CycD-147: gct cct gtg ctg cga agt gg 
CycD-220: ctc cgt ctt gag cat ggc tcg 
 
CycB-351: cca gag gtg gaa ctt gct gag c 
CycB-481: ggc gca cat cca gat gtt tcc 
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Cyclin A-54: tga tgc ttg tca aat gct cag c 
Cyclin A-155: agg tcc tcc tgt act gct cat 
 
Ncf1-8: aca cct tca ttc gcc ata ttg c 
Ncf1-115: tcg gtg aat ttt ctg tag acc ac 
 
Sestrin3: sense cat gcg ttt cct cac tca ga 
Sestrin3: antisense ggc aaa gtc ttc gta ccc aa 
 
Albumin-285: aga taa gtt gtg tgc cat tcc aa 
Albumin-368: tgt gtt gca gga aac att cgt 
 
Nemo-Real time sense: aag cac ccc tgg aag aac c 
Nemo-Real time antisense: cct gct ctg aag gca gat gta 
 
Cre “Debuck”: ttt ccc gca gaa cct gaa gat g 
Cre “Debuck”: atc cgc cgc ata acc agt g 
 
2.10. General protocol for immunofluorescence  
Cryosections of frozen livers were performed and slides were fixed in appropriate fixating 
agent, 70% methanol-30% acetone for p65 (sc-109 Santa Cruz Biotechnology Inc), 10 min 
at room temperature and in 4% Paraformaldehyde for CD11b (Serotec), Ki67 and HNF4α 
(Santa Cruz) 10 min at RT. Slides were blocked and incubated overnight with the primary 
antibody anti-p65, anti-cd11b, anti-Ki67 or anti-HNF4α. As secondary antibody we used a 
goat-anti-rabbit labeled with Cy-3 (Jackson Research) for p65, a goat-anti-rat Cy-3 
(Jackson Research) labeled secondary for CD11b and a donkey-anti-goat (Jackson 
Research) for Ki67 and HNF4α 
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2.10.1. BrdU and Histone H3 staining 
BrdU-Staining  
2 hours before sacrificing the animals, 200 µg 5-bromo-2'-deoxyuridine (BrdU) were 
injected intraperitoneally to label proliferating cells in the S phase of the cell cycle. Staining 
was performed according to the Cell Proliferation Kit manual (RPN20; GE Healthcare). 
Liver samples were analyzed counting the number of BrdU-positive cells and the total 
number of cells per view field (200x-magnification) for at least 4 animals per time point.  
For analysis of periportal proliferation, pictures were retrieved as described above, the 
periportal regions were marked manually and counting was only performed on this regions 
Hepatocyte proliferation was detected by immunofluorescence through 5-bromo-2´-
deoxyuridine (Amersham Pharmacia) incorporation to the nuclei of hepatocytes undergoing 
DNA synthesis. BrdU staining was performed in frozen liver sections and as secondary 
antibody we used a goat anti-mouse Cy-3 labeled from Jackson Research. Quantification of 
positive proliferating hepatocytes was performed by counting BrdU positive nuclei relative to 
the total nuclei per power field (200x) stained with DAPI.  
 
Histone H3 staining 
Immunofluorescence using an anti-phospho-Histone-3 antibody (Cell Signaling) was 
performed on frozen liver sections to asses the presence of mitotic bodies after PH. As 
secondary antibody we used a goat-anti-mouse labeled with FITC. Percentage of mitotic 
cells was quantified following the same procedure than for BrdU.  
 
2.10.2. CK19 staining 
Cryosections of frozen livers were air-dried for 5 minutes at room temperature then fixed in 
pre-cooled (-20°C) 1:1 acetone/methanol solution for 6 minutes at -20°C. Slides were then 
dried 5 minutes, rehydrated in PBS 1X for 10 minutes and washed 3 times in TBS-T for 5 
minutes. 
Slides were blocked in TBS-T 10% FCS for 1h at RT and then incubated overnight with the 
primary antibody CK19 sc-33111 (1:200) or CK19 hybridoma bank (1:100). As secondary 
antibody a donkey-anti-goat labeled with Cy-3 (Jackson Research) or donkey anti-rat 
labeled with FITC (Jackson Research) 
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2.10.3. TUNEL assay 
The terminal deoxynucleotidyl transferase dUTP nick-end-labeling (TUNEL) staining was 
performed using the “In situ cell death detection Kit, Fluorescein” from Roche Applied 
Science. 
Slides were air-dried for 1h at room temperature then fixed in freshly made 4% buffered 
paraformaldehyde for 45 min. Slides were then washed twice in PBS 1x for 5 min and 
incubated in 3% peroxydase diluted in methanol for 10 min at RT and then washed 10 min 
in PBS. Next, slides were incubated in cold sodium citrate 150mM for 2 min at 4°C then 
washed 2 times in PBS for 5 min at RT. Finally slides were incubated with the enzyme 
solution for 1h at 37°C (or overnight at 4°C for stronger signal), washed twice in PBS and 
mounted in mounting medium containing DAPI.  
 
Enzyme dilution: 
1 µl of enzyme FITC-labeled + 4 µl of TUNEL Dilution Buffer (1/5 dilution) + 45 µl of buffer 
provided in the kit. 
 
2.10.4. DHE staining 
Fresh slides werefixed shortly in cold acetone/methanol (1/1) for 5 min, washed twice in 
PBS and then incubated with 5 µM of dihydroethidium diluted in PBS for 30 min at 37°C. 
Slides were then washed 3 times in PBS and mounted in Vectashield. 
 
2.11. Immunohistochemistry 
Hematoxylin-eosin staining (H&E) was performed on paraffin-embedded liver sections by 
the department of Pathology in the University Hospital Aachen. 
In the first step, the nuclei are stained with a hematoxylin solution. The nuclei stain blue, 
dark violet to black. The second step is counterstaining with a xanthene dye, e.g. eosin. In 
this process cytoplasm, collagen, keratin and erythrocytes stain red. 
Staining intensity may differ along reagents batches and/or experimentator. 
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2.12. Analysis 
2.12.1. Image analysis 
Image J version 1.4 was used for picture analysis. Cells were counted using the Cell 
Counter from Image J which allows the user to count up to 8 different cell populations at the 
same time. Fluorescence quantification was used only for CK19 staining due to the high 
specificity of the staining resulting in no background signal at all. 
Image J was set in order to measure the threshold only (Analyse > Set measurement > 
select Limit to threshold). Open the picture with the CK19 fluorescent channel, go to 
Process > Binary, select Make Binary. Then go to Analyse > Measure. 
 
2.12.2. Flow cytometry analysis 
One million of events were acquired using the BD FACSDiva software on the BD FACS 
Canto II Analyzer. Data were then exported and analyzed in the Flow Jo software from Tree 
Star Inc. 
2.12.3. Statistical analysis 
Data are expressed as Mean ± Standard deviation of the mean (sdm). Statistical 
significance was determined by 2-way analysis of variance followed by Student’s T test. 
GraphPad Prism version 5 from GraphPad Software was used for the second part of the 
thesis. 
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3. Results part I 
 
3.1. IKK2 hepatocyte-specific deletion modifies IκB-α 
phosphorylation and NF-κB activation after PH 
After stimulation, the IKK complex gets activated by phosphorylation of the 
catalytic subunits IKK1 and IKK2. These kinases phosphorylate IκB, triggering this 
way NF-κB nuclear translocation and target gene activation. Previously generated 
hepatocyte-specific IKK2 KO mice (IKK2Δhepa) showed effective IKK2 deletion in 
hepatocytes (Luedde, Assmus et al. 2005). PH was performed in these KO mice and 
WT controls (IKK2f/f) and we first studied the impact of IKK2 deletion in the IKK 
complex during liver regeneration using an IKK1/2 phospho-specific antibody 
(Ser176/180). In IKK2f/f we observed transient IKK1/2 phosphorylation 1 hour after 
PH (Fig. 1A), while strong phospho-IKK1/2 expression was found in IKK2Δhepa 1, 3 
and 6 hours after PH (Fig. 1A). No significant differences in IKK1 protein level were 
evident between the two mice strains at different time points after PH (Fig. 1A).  
We then tested if lack of hepatocytic IKK2 expression and strong IKK 
activation alters IκB-α phosphorylation after PH. In IKK2f/f mice high p-IκB-α 
expression was already found 1 hour after PH and lower IκB-α phosphorylation was 
evident 6h after surgery (Fig. 1B). In IKK2Δhepa mice p-IκB-α expression was detected 
starting 3 hours after PH indicating delayed NF-κB activation in IKK2Δhepa mice (Fig. 
1B). These data suggest that IKK2 deletion trigger increased IKK1 activation, which 
is known to mainly activate the NF-κB non-canonical pathway. Activation of this 
alternative signaling pathway may lead to the delayed IκB-α phopshorylation 
(Senftleben, Cao et al. 2001). 
 
Fig. 1. Hepatocyte-specific IKK2 deletion attenuates parenchymal NF-κB activation after PH. (A) 
Western blot analysis of p-IKK1/2, total IKK1, and (B) p-IκB-α before and 1, 3, and 6 hours after PH. 
GAPDH and α-tubulin (lower panel) were used as loading controls.  
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As these results demonstrated altered IKK complex activity in IKK2Δhepa mice, 
we now investigated NF-κB nuclear translocation after PH in both animal strains by 
immunofluorescence (IF) using a p65 antibody. The p65 antibody used in this study 
binds to the N-terminal part of p65, which interacts with IκB and therefore non 
stimulated cells remain p65 negative (Phelps, Sengchanthalangsy et al. 2000). In 
order to dissect the cellular distribution of NF-κB activation we co-stained with a 
F4/80 antibody, which labels Kupffer cells. In IKK2f/f mice, p65 staining was positive 1 
hour after liver resection in hepatocytes (full arrows pointing down) while 3 hours 
after PH, non-parenchymal cells became positive as evidenced by p65-F4/80 co-
localisation (thin arrows pointing up) (Fig. 2). In IKK2Δhepa mice, no p65 response 
could be detected in hepatocytes 1 hour after resection, while positive signals were 
detected in non-parenchymal cells – most likely Kupffer cells as they are also positive 
for F4/80 (Fig. 2). 3 hours after resection NF-κB positive hepatocytes were detected 
in IKK2Δhepa (Fig. 2). 
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Fig. 2. Immunohistochemistry using p65 + Cy3-labeled secondary Ab and F4/80 + FITC-labeled 
antibodies in livers of IKK2f/f and IKK2Δhepa mice before and 1 and 3 hours after PH (left panel). DAPI 
staining was performed to detect nuclei. Merged picture (right panel) of p65 (left panel) and F4/80 
stainings (middle panel). Thin arrows pointing up show Kupffer cell p65 staining; full arrows pointing 
down show hepatocyte p65 staining. 
In summary, lack of IKK2 expression in hepatocytes alters the NF-κB 
activation pattern in both parenchymal and non-parenchymal liver cells after PH. 
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3.2. Lack of hepatocyte IKK2 promotes earlier cell cycle entry after 
PH 
Kupffer cell derived TNF production is induced after PH, triggering NF-κB 
activation (Fausto, Campbell et al. 2006). As expected, liver TNF expression 
increased in IKK2f/f animals up to 6 hours after PH whereas in IKK2Δhepa mice, it was 
significantly increased already 1h after resection remaining elevated at 3 and 6 hours 
after surgery (Fig. 3A). 
TNF-dependent c-Jun-N-terminal kinase (JNK) activation is involved in 
triggering cell cycle progression after PH (Diehl, Yin et al. 1994; Yamada, Kirillova et 
al. 1997; Schwabe, Bradham et al. 2003). Kinase assays of IKK2f/f mice whole liver 
extracts showed transient JNK activation 1 hour after PH while IKK2Δhepa mice 
exhibited stronger and sustained JNK activity during the initial time points after liver 
resection (Fig. 3B).  
 
Fig. 3. (A) IKK2Δhepa  mice exhibit earlier cell cycle priming after PH. TNF protein expression detected 
by enzyme-linked immunosorbent assay in livers of IKK2
f/f 
and IKK2Δhepa  mice. Solid lines represent 
IKK2
f/f
; dashed lines represent IKK2Δhepa  (n = 4 animals/time point; ***P <0.001, **P<0.01 [IKK2
f/f 
versus IKK2Δhepa ]). (B) JNK activity was detected in whole liver extracts showing stronger and 
sustained kinase activity in IKK2Δhepa  mice after PH.  
C-myc mediates early cell cycle progression of hepatocytes as it is shortly 
activated after PH as part of the immediate-early gene response (Fausto 2000). In 
IKK2f/f mice, c-myc mRNA expression increased already 3h after PH and peaked 6h 
after surgery (Fig. 4A). Unexpectedly, faster c-myc expression was evident in 
IKK2Δhepa animals as levels were found maximal 3h after PH. 
In the early phase of liver regeneration, extracellular matrix (ECM) degradation 
allows release of growth factors that promote hepatocyte proliferation (Rana, 
Mischoulon et al. 1994; Rudolph, Trautwein et al. 1999). Matrix metalloproteinase-9 
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(MMP-9) is produced in response to TNF and mediates ECM degradation (Olle, Ren 
et al. 2006). Zymography analysis showed that in IKK2f/f animals MMP-9 proteinase 
activity was transiently activated 6 hours after PH, while in IKK2Δhepa mice earlier and 
prolonged MMP-9 activity was observed (Fig.4B).  
 
Fig. 4. Real-time PCR for c-myc liver mRNA expression (A) in IKK2Δhepa and IKK2
f/f 
mice before and 
after PH. Zymography to determine MMP-9 gelatinase activity (B) in IKK2Δhepa  mice and IKK2
f/f 
mice 
before and after PH. Two representative samples from each time point and genotype are shown. The 
position of the digested band is shown by an arrow. Solid lines represent IKK2f/f; dashed lines 
represent IKK2Δhepa  
These results suggest that lack of IKK2 expression triggers hepatocytes to 
leave earlier the quiescent (G0) state. 
 
3.3. Earlier S-phase progression and hepatocyte proliferation in 
IKK2Δhepa mice after PH 
Next, we analyzed G1/S progression of hepatocytes in IKK2Δhepa mice after 
PH. Immunofluorescence-based BrdU analysis and quantification of proliferating cells 
was performed in IKK2f/f and IKK2Δhepa mice between 24 and 72 hours after PH. 
Between 24 and 40h after liver resection significantly more BrdU positive hepatocytes 
were found in IKK2Δhepa mice and maximal DNA-synthesis was evident 48 hours after 
PH (Fig. 5). In IKK2f/f mice a single and pronounced peak of DNA synthesis was 
found 48h after PH and the number of proliferating cells was higher than IKK2Δhepa 
mice at this time point. 
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Fig. 5. IKK2 deletion in hepatocytes accelerates hepatocyte proliferation after PH. 
(A) Immunohistochemistry using a BrdU antibody followed by a Cy3-labeled secondary antibody in 
livers of IKK2
f/f 
and IKK2Δhepa mice before and between 24 and 72 hours after PH (upper panel). 
Merged DAPI and BrdU staining is shown in the lower panels. (B) Quantification of BrdU-positive cells 
relative to total nuclei (DAPI) per x200 power field. Solid lines represent IKK2
f/f
; dashed lines represent 
IKK2Δhepa  (n = 4 animals/time point; **P <0.01, ***P<0.001 [IKK2
f/f 
versus IKK2Δhepa ]).  
 
To further confirm these results, we studied expression of factors involved in 
cell cycle control. Differential Cyclin D1 expression was found between mouse strains 
as in IKK2Δhepa protein level peaked 24 hours after PH while in WT littermates it was 
found maximal at 40 hours after resection (Fig. 6A). Cyclin E mRNA analysis showed 
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maximal up-regulation in IKK2Δhepa 40 hours after PH that was delayed to 48 hours in 
WT mice (Fig. 6B).  
 
Fig. 6. Lack of hepatocyte IKK2 expression triggers earlier G1/S phase transition after PH. (A) 
Western blot analysis for Cyclin D1 expression of whole protein liver extracts of IKK2f/f and IKK2Δhepa  
mice at time points before and after PH. (B) Real-time PCR for liver Cyclin E mRNA expression of 
IKK2f/f and IKK2Δhepa  animals at time points before and after PH. Solid lines represent IKK2f/f; dashed 
lines represent IKK2Δhepa . 
Cyclin A mRNA expression was first elevated 40h after PH in IKK2Δhepa mice, 
while in WT mice no significant increase could be observed at this time point (Fig. 
7A). At 48h Cyclin A expression peaked in both groups, but was found higher in 
IKK2f/f animals (Fig. 7A). Western Blot analysis confirmed earlier Cyclin A activation 
in IKK2Δhepa mice (Fig. 7B).  
 
 
Fig. 7. Liver Cyclin A mRNA (A) and protein (B)  expression in IKK2f/f and IKK2Δhepa  mice before and 
after PH. Solid lines represent IKK2f/f; dashed lines represent IKK2Δhepa  [n = 4 animals/time point; *P < 
0.05, **P  < 0.01 (IKK2f/f versus IKK2Δhepa )]. 
These results demonstrate earlier G1/S-phase progression and DNA synthesis 
in IKK2Δhepa mice after PH. 
Results 51 
 
3.4. Prolonged mitotic phase in IKK2Δhepa mice after PH  
Cells remain arrested in G2 phase when Cyclin B1 forms a complex with Cdc2 
(also known as Cdk1) that is inactive upon Tyr-15 and Thr-14 phosphorylation 
(Sebastian, Kakizuka et al. 1993). G2/M phase progression occurs after de-
phosphorylation of Cdc2 by Cdc25C phosphatase (Schmitt and Nebreda 2002). 
Cyclin B1 mRNA expression was not different between IKK2Δhepa and IKK2f/f mice 
(Fig. 8A.). However, a different kinetic in Cdc2 activation was observed. In IKK2Δhepa 
faster progression into the mitotic phase occurred as we found earlier 
phosphorylation of Cdc2 that was de-phosphorylated (and thus activated) 60h after 
PH, while in IKK2f/f mice a certain degree of phosphorylated-Cdc-2 (inactive form) 
could be still detected at this time point (Fig. 8B).  
 
Fig. 8. Misregulation of mitosis in hepatocyte-specific IKK2-deleted mice after PH. (A) Real-time PCR 
for liver Cyclin B1 mRNA expression in IKK2f/f and IKK2Δhepa  mice before and after PH. (B) Phospho-
Cdc2 expression as evidenced via Western blot analysis in IKK2f/f and IKK2Δhepa  mice. Solid lines 
represent IKK2f/f; dashed lines represent IKK2Δhepa.  
Phosphorylation of Histone H3 is essential for chromosome condensation and 
progression from G2 to Mitosis (Nowak and Corces 2004). Immunohistochemistry 
using a phospho-Histone H3 antibody and its quantification evidenced initiation of 
mitosis in both mice strains at 60 hours after PH (Fig.9). 
Results 52 
 
Fig. 9. (A) Immunofluorescence with a phospho-Histone H3 antibody before and between 60 and 96 
hours after PH in IKK2f/f and IKK2Δhepa mice (upper panel). Merged DAPI and anti-phospho-Histone H3 
staining is shown in the lower panel. (B) Quantification of anti-phospho-Histone H3 positive cells in 
livers of IKK2f/f and IKK2Δhepa  mice. Solid lines represent IKK2f/f; dashed lines represent IKK2Δhepa  (n = 
4 animals/time point; ***P < 0.001 [IKK2f/f versus IKK2Δhepa ]). 
 
However, while mitotic rate remained at the same level in IKK2f/f mice at 72 
hours after PH, we observed significant increase in IKK2Δhepa mice. After 96h still few 
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p-Histone H3 positive cells could be detected while at this time no mitosis could be 
detected in IKK2f/f animals.  
ECM modulation is important in order to shift hepatocytes in a differentiated 
and quiescent state (Rudolph, Trautwein et al. 1999). Differences in ECM 
degradation were evident between the two mouse strains at late time points after PH. 
In IKK2f/f animals MMP-9 activity was detected between 24 and 48h (Fig. 10), while in 
IKK2Δhepa mice it was found later from 48h up to 60h after PH.  
 
Fig. 10. Zymography for MMP-9 gelatinase activity in IKK2Δhepa  mice occurred later than in IKK2f/f 
mice after PH. Two representative samples from each time point and genotype are shown. The 
position of the digested band is shown by an arrow. 
 
Together these results suggest that IKK2Δhepa mice require a prolonged mitotic phase 
in order to reach a quiescent state after PH.  
 
3.5. Stronger CXCL1 and acute phase gene expression in IKK2Δhepa 
mice after PH 
Recent studies highlighted the role of the innate immune response during liver 
regeneration (Strey, Markiewski et al. 2003; Seki, Tsutsui et al. 2005; Campbell, 
Riehle et al. 2006) where pro-inflammatory cytokines and acute phase genes (APG) 
play a main role. Our first results demonstrated that dysregulation of NF-κB activation 
was accompanied by high TNF expression in IKK2Δhepa mice leading to earlier 
priming. Besides TNF, also IL-6 is involved in triggering hepatocytes to leave their 
quiescent state. Liver IL-6 expression increased in both IKK2f/f and IKK2Δhepa mice 
during the first 6 hours after PH, however no significant differences were found 
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between the two mouse strains (Fig. 11A). This result was further confirmed as no 
significant difference in nuclear phospho-STAT-3 expression was found between 
both groups after PH (Fig. 11B). 
 
Fig. 11. Normal IL-6 signaling in IKK2Δhepa mice. (A) IL-6 protein expression detected via enzyme-
linked immunosorbent assay at time points before and after PH in livers of IKK2f/f and IKK2Δhepa  mice. 
(B) Western blot analysis of whole liver extracts of IKK2f/f and IKK2Δhepa animals for phospho-STAT-3 
expression before and after PH. GAPDH was used as a loading control. Solid lines represent IKK2f/f; 
dashed lines represent IKK2Δhepa. 
Serum Amyloid A (SAA) is one of the main APR proteins and part of the 
unspecific defense in mice after liver injury (Trautwein, Boker et al. 1994; Rudolph, 
Trautwein et al. 1999). Maximal SAA levels were found in IKK2f/f and IKK2Δhepa mice 
24 h after PH. However, earlier and more intense APR was detected in IKK2Δhepa 
livers as evidenced by the 200 fold-increase in SAA expression found already 6 h 
after liver resection (Fig. 12A).  
CXC chemokines like CXCL-1 attract neutrophils to sites of inflammation 
during early stages of wound healing facilitating tissue repair (Charo and Ransohoff 
2006). We found that basal CXCL-1 mRNA expression was higher in livers of 
IKK2Δhepa compared to IKK2f/f animals (Fig. 12B). After PH, CXCL-1 expression in 
IKK2f/f mice increased over time during the early 24 hours, whereas a dramatically 
faster and stronger up-regulation was evident in IKK2Δhepa animals (Fig. 12B).  
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Fig. 12. Earlier and stronger inflammatory response in hepatocyte-specific IKK2 knockout mice. Real-
time PCR to analyze liver mRNA levels in IKK2f/f and IKK2Δhepa  mice for (A) SAA and (B) CXCL-1 
before and after PH. Solid lines represent IKK2f/f; dashed lines represent IKK2Δhepa (n = 4 animals/time 
point; *P < 0.05, **P < 0.01, ***P < 0.001 [IKK2f/f versus IKK2Δhepa ]). 
Together these data indicate an earlier and stronger chemoattractant and APR 
response in IKK2Δhepa after PH. 
 
3.6. IKK2Δhepa mice show enhanced recruitment of inflammatory 
cells after PH 
To study if the increased chemoattractant response observed in IKK2Δhepa 
mice correlated with stronger mobilization of PMNs, we performed FACS analysis 
and white blood counts (WBC) of blood samples collected from IKK2f/f and IKK2Δhepa 
mice before and 12 hours after PH. In untreated animals from both strains a 
comparable percentage of CD11b+/Gr1+ cells, mainly PMNs, were detected in 
peripheral blood (Fig. 13A). 12 hours after PH in IKK2Δhepa this cell population 
increased, while no regulation was evident in IKK2f/f mice (Fig. 13A). 
We then investigated if increased PMN mobilization in IKK2Δhepa mice after PH 
correlated with a higher recruitment to the liver (Fig. 13B). Before PH in both strains 
similar numbers of liver resident CD45+/CD11b+/Gr1+/F4/80- cells - mainly PMNs - 
could be detected. 12h after PH the amount of these cells did not significantly 
increase in IKK2f/f animals, while livers of IKK2Δhepa mice already revealed a 3.5 fold 
increased content of CD45+/CD11b+/Gr1+/F4/80- cells compared to the basal level 
and control WT littermates. These results suggested that the earlier inflammatory and 
chemoattractant response in IKK2Δhepa after PH had a direct impact on mobilization of 
neutrophils to the blood stream and recruitment to the liver.  
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Fig. 13. Mobilization and recruitment of inflammatory cells after PH. (A) FACS analysis of peripheral 
blood leukocytes before (left panel) and 12 hours after PH (right panel). Fraction of CD11b+ cells is 
given in percentage of total leukocytes. Diagram shows total number of CD11b+/Gr1+/CD115- cells 
(PMNCs) in the peripheral blood at the given time points. (B) Fluorescence-activated cell sorting 
analysis of immune cells isolated from hepatic tissue before and 12 hours after PH. Dot plots show 
CD11b and F4/80 expression of cells pre-gated for CD45+ respectively. Bar chart shows the absolute 
frequency of CD11b+/Gr1+/F4/80- cells (mainly PMNCs) displayed as the percentage of total liver 
cells (normalized to CD45+ cells). Black bars represent IKK2f/f; grey bars represent IKK2Δhepa (n = 4 
animals/time point; *P < 0.05 [IKK2f/f versus IKK2Δhepa ]). 
This finding was further confirmed by immunofluorescence of liver sections 
using a CD11b antibody supporting a more pronounced infiltration of CD11b+ cells 
after PH in IKK2Δhepa mice (Fig. 14). 
Results 57 
 
Fig. 14. Immunofluorescent staining of frozen liver sections for CD11b+ confirmed the results obtained 
via fluorescence-activated cell sorting (red, CD11b-positive cells; blue, DAPI-stained nuclei). 
 
3.7. Systemic IKK2 inhibition with AS602868 does not affect 
hepatocyte proliferation after PH.  
Our data showed that hepatocyte-specific IKK2 deletion is associated with a 
proliferative advantage after PH. Therefore, we tested if systemic inhibition is also 
associated with earlier proliferation after PH. We thus applied an IKK2 inhibitor 
AS602868 in a dose we used in previous experiments to block IKK2 after 
ischemia/reperfusion injury (Luedde, Assmus et al. 2005)
 
and to block progression of 
NASH (Luedde, Assmus et al. 2005) 
We administered AS602868 24 hours and 1 hour before PH as well as 24 hours after 
PH. AS602868 treatment compared with controls (vehicle) had no impact on the 
increase and the maximum of BrdU synthesis 40 and 48 hours after PH (Fig. 15A, B).  
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Fig. 15. Systemic pharmaceutical IKK2 inhibition with AS602868 had no impact on hepatocyte 
proliferation after PH. (A) Immunohistochemistry using BrdU and a Cy3-labeled antibody in livers orally 
treated with AS602868 or vehicle showed no significant differences between treatment groups 
(AS602868 versus vehicle). (B) Solid lines represent quantification of BrdU-positive cells relative to 
vehicle; dashed lines represent AS602868 (n = 5 animals/time point). 
These results indicate that systemic, in contrast to hepatocytic IKK2 inhibition, 
has no impact on cell cycle progression after PH.  
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4. Results part II 
In order to investigate the relevance of the regulatory subunit of the IKK 
complex during liver regeneration we performed partial hepatectomy to NemoΔhepa 
mice and the results are described in part II. 
4.1. NemoΔhepa mice die massively after partial hepatectomy 
As it is widely known, 70% PH (or 2/3 PH) is a non-lethal surgical procedure, 
on the contrary to 90% PH (Makino, Togo et al. 2005). In fact 100% of both of IKK2f/f 
and IKK2Δhepa mice survived the challenge. Interestingly, 50% of the NemoΔhepa mice 
die during the regeneration process, generally between 24 and 120h post surgery, 
with a higher frequency within the first 48 hours (Fig 16). As expected, all Nemof/f 
survived the surgery. 
 
   
Fig. 16. Kaplan-Meier curve of surviving mice after partial hepatectomy. Dashed lines represent 
Nemof/f, solid line represents NemoΔhepa mice (*** p<0.001 [Nemof/f versus NemoΔhepa]). 
A healthy liver is protected from apoptosis during the regeneration process, 
NF-κB is activated, resulting in induction of anti-apoptotic genes (Iimuro, Nishiura et 
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al. 1998). Tunel assay performed on cryosections evidenced massive liver apoptosis 
in NemoΔhepa mice between 32h and 48h after PH (Fig. 17A). Quantification of tunel 
positive cells (Fig. 17B) confirmed the significantly higher apoptosis between 32 and 
48h in NemoΔhepa animals. The basal apoptosis observed in untreated animals can be 
better explained by our previous findings that showed that Nemo deletion promotes 
spontaneous liver damage and hepatocyte apoptosis (Luedde, Beraza et al. 2007; 
Beraza, Malato et al. 2009). 
 
 
Fig. 17. (A) TUNEL assay on frozen section (green, Tunel-positive cells; blue, DAPI-stained nuclei) 
and (B) quantification of positive cells. White bars represent Nemof/f, black bars represent NemoΔhepa 
animals (*** p<0.001 [Nemof/f versus NemoΔhepa]). 
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4.2. Hepatocyte specific deletion of nemo modifies the proliferative 
response after partial hepatectomy 
We then analysed the proliferative response of hepatocytes in surviving 
NemoΔhepa mice after PH. Quantification of proliferating cells using an 
immunofluorescence-based BrdU analysis was performed in Nemof/f and NemoΔhepa 
mice between 32h and 15d after PH. Previous studies (Luedde, Beraza et al. 2007; 
Beraza, Malato et al. 2009) reported that the absence of Nemo in hepatocytes 
triggers the cell cycle in an attempt to compensate the apoptosis undergoing in 
hepatocytes lacking Nemo. In this line, in our present study we could show that 
surviving NemoΔhepa mice (with strong liver apoptosis) underwent hepatocyte 
proliferation after PH but this was severely modified when compared to WT 
littermates. Whereas Nemof/f animals showed a peak of proliferation at 48h after PH, 
NemoΔhepa mice proliferated less intensively (Fig. 18A) and at a more constant rate 
(Fig. 18B).  
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Fig. 18. Nemo deletion in hepatocytes alters hepatocyte proliferation after PH. (A) 
Immunohistochemistry using a BrdU antibody followed by a Cy3-labeled secondary antibody in livers 
of Nemof/f 
 
and NemoΔhepa mice before and between 32 hours and 15 days after PH (upper panel). 
Quantification of BrdU-positive cells relative to total nuclei (DAPI) per x200 power field (lower panel). 
White bars represent Nemof/f; black bars represent NemoΔhepa (n = 4 animals/time point; **P <0.01, 
***P<0.001 [Nemof/f versus NemoΔhepa]).  
Western blot analysis of Cyclin A showed a different regulation in the peak of 
its expression in the NemoΔhepa mice (Fig. 19). While WT animals showed Cyclin A 
protein expression 48h after PH, corresponding to the peak of BrdU proliferation, 
NemoΔhepa mice had increased Cyclin A expression from 32h to 72h after PH. Cdk2 a 
Cyclin dependant kinase, is essential for the G1/S phase transition by binding with 
Cyclin A. Cdk2 activity is regulated by its phosphorylation that leads to 
downregulation of Cdk2 expression levels. After PH, Cdk2 downregulation was 
observed at 48h and 72 h in Nemof/f animals whereas in NemoΔhepa mice exhibited 
constant Cdk2 expression highlighting a misregulated cell cycle in these mice. 
Interestingly, untreated NemoΔhepa mice exhibited a lower liver weight/body 
weight ratio, which was maintained during the first steps of liver regeneration (Fig. 
20). On the contrary, a significantly higher LW/BW ratio was measured 15d after PH.  
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Fig. 19. Western Blot analysis of whole liver extracts of Nemof/f and NemoΔhepa animals for Cyclin A 
and Cdk2 before and after PH. GAPDH was used as a loading control. 
 
Fig. 20. Liver weight/body weight ratio before and after partial hepatectomy. White bars represent 
Nemof/f; black bars represent NemoΔhepa (n = 5 animals/time point; **P <0.01, ***P<0.001 [Nemof/f 
versus NemoΔhepa]). 
 
4.3. Partial hepatectomy leads to a strong oval cell response in 
NemoΔhepa mice 
In mammals, hepatocytes can rapidly proliferate upon acute liver injury to 
overcome the loss of liver tissue. During chronic injuries, when hepatocytes’ ability to 
divide is impaired, a new population of cells may rise. This cell population has a 
diverse nomenclature (hepatic progenitor cells, liver stem cell) although they are 
commonly named as oval cells. Although the origin of these cells remains 
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controversial (Petersen, Grossbard et al. 2003; Wang, Foster et al. 2003), it is well 
known that they express markers of both the biliary epithelium (CK19) and the 
hepatocyte lineage (albumin). 
 As mentioned before, NemoΔhepa livers show signs of steatohepatitis (Luedde, 
Beraza et al. 2007; Beraza, Malato et al. 2009) and activation of progenitor cells can 
be found spontaneously in livers from untreated NemoΔhepa animals (Luedde, Beraza 
et al. 2007). Moreover, PH triggered a staggering strong and fast oval cell reaction in 
NemoΔhepa mice that lasted for at least 15 days after PH in the KO livers (Fig. 21). 
As expected and confirming what is described in the literature (Fausto 2004; Fausto, 
Campbell et al. 2006) WT livers did not show any sign of oval cell activation 
 
 
Fig. 21. Partial hepatectomy triggers a fast oval cell response in NemoΔhepa mice. 
Immunohistochemistry using a CK19 antibody followed by a Cy3-labeled secondary antibody in livers 
of Nemof/f 
 
and NemoΔhepa mice before and between 6 hours and 15 days after PH (left panel). (Red: 
CK19, blue: DAPI, magnification: 200x). 
Fluorescence quantification performed with the software Image J confirmed a 
strong induction of CK19 positive cells after partial hepatectomy, which correlates 
with CK19 mRNA level analysed by Real-Time PCR (Fig. 22). 
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Fig. 22. CK19 fluorescence quantification (left panel) and CK19 Real-Time PCR (right panel). 
Quantification of total CK19 fluorescence intensity was analyzed using Image J software per x200 
power field. White bars represent Nemof/f; black bars represent NemoΔhepa (n = 4 animals/time point; 
***P<0.001 [Nemof/f versus NemoΔhepa]). 
 This massive induction of oval cells raised the problem to know whether the 
proliferative cells observed in the BrdU staining were indeed hepatocytes or oval cells 
in NemoΔhepa animals. To answer this question, the staining strategy had to be 
adapted. The BrdU staining is incompatible for double labeling, thus we had to use 
Ki67 staining for double labeling experiments. Ki67 is a marker of proliferative cells, 
although not specific for a mitotic phase. Our first double staining involved CK19 and 
Ki67 and it showed that most of the proliferative cells were not CK19 double positive 
(Fig. 23 upper panel). The second strategy used the hepatocyte marker HNF4α co-
stained with Ki67, and the results displayed a preponderance of cells double positive 
for Ki67 and HNF4α confirming that the vast majority of proliferative cells in 
NemoΔhepa were indeed hepatocytes. 
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Fig. 23. Hepatocytes are proliferating in NemoΔhepa mice after PH. Immunohistochemistry using a Ki67 
antibody followed by a Cy3-labeled secondary antibody and CK19 antibody followed by a FITC 
labeled secondary in NemoΔhepa livers 48 hours after PH (upper panel). Immunohistochemistry using a 
Ki67 antibody followed by a FITC-labeled secondary antibody and HNF4α antibody followed by a Cy3 
labeled secondary in NemoΔhepa livers 15 days after PH (lower panel), magnification: 200x.  
 
4.4. Impaired priming phase in NemoΔhepa mice 
In order to understand why hepatocytes lacking nemo did not proliferate 
properly, we analyzed the priming phase, when hepatocytes get the signals to start 
the proliferative machinery. This phase relies on the activation of inflammatory 
cytokines like TNF-α and IL-6 (Cressman, Greenbaum et al. 1996; Yamada, Webber 
et al. 1998), and IL-1β. Kupffer cell derived TNF production is shortly induced after 
PH triggering NF-κB activation and IL-6 production (Fausto, Campbell et al. 2006). 
ELISA assay of total liver extracts showed a strong TNF-α upregulation in control 
NemoΔhepa livers (Fig. 24A), (possibly as a result of the pre-existing activation of the 
Kupffer cells that may contribute to the inflammatory environment observed in these 
livers).  
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Fig. 24. Elisa measurement of liver extracts for TNF-α (A) and IL-6 (B) pro inflammatory cytokines.  
Dashed lines represent Nemof/f, solid lines represent NemoΔhepa mice (* p<0.05; *** p<0.001 [Nemof/f 
versus NemoΔhepa]). 
Surprisingly, after PH TNF-α protein levels decreased in NemoΔhepa while it 
rose over time in Nemof/f livers. In addition, the kinetics of IL-6 protein expression 
was also significantly deregulated in KO livers, with a constantly low level of 
expression in the KO livers (Fig. 24B). 
IL-6 signaling via gp130 leads to STAT3 activation. Accordingly, STAT3 
activation (illustrated by phosphorylation) was almost abolished in NemoΔhepa livers 
(Fig. 25A). Consequently, SAA mRNA expression (Fig. 25B) was significantly 
reduced in these mice compared to WT animals at all the time points analyzed. 
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Fig. 25. Western blot analysis of whole liver extracts of Nemof/f and NemoΔhepa animals for phospho-
STAT-3 expression before and after PH. GAPDH was used as a loading control (A). Real-Time PCR 
of SAA before and after PH (B). White bars represent Nemof/f, black bars represent NemoΔhepa mice        
(* p<0.05; ** p< 0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]). 
Additional analysis demonstrated a profound dysfunction in IL-6 signaling. 
Real-Time PCR for IL-6R (Fig. 26A) and gp130 (Fig. 26B), respectively co-receptor 
and receptor of IL-6, showed significantly lower mRNA levels in NemoΔhepa compared 
to Nemof/f littermates after PH in total liver.  
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Fig. 26. Real-Time PCR of whole liver extracts from Nemof/f and NemoΔhepa mice for IL-6R (A) and 
gp130 (B) before and after PH. White bars represent Nemof/f, black bars represent NemoΔhepa mice     
(* p<0.05; ** p< 0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]).  
Moreover, mRNA extracted from isolated hepatocytes showed significantly 
reduced mRNA expression for IL-6R, gp130 and MyD88 in hepatocytes lacking 
Nemo (Fig. 27). The remnant expression of IL-6R, gp130 and MyD88 around 20-25% 
led us hypothesize that our primary cultures contained traces of other cell types.  
 
Fig. 27. Real-Time PCR of isolated hepatocytes from Nemof/f and NemoΔhepa mice for Gp130, IL-6R , 
MyD88, Nemo and F4/80. White bars represent Nemof/f, black bars represent NemoΔhepa mice          
(*** p<0.001 [Nemof/f versus NemoΔhepa]).  
 
Hepatocytes isolation leads usually to a relatively pure population of 
hepatocytes. However, as described previously, Nemo deletion leads to a fibrotic 
phenotype (Luedde, Beraza et al. 2007) and this accumulation of collagen fibers 
possibly interferes with the purity of the isolation of hepatocytes. Real-Time PCR 
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confirmed remnant expression of Nemo (25%) in KO hepatocytes. More importantly 
F4/80 mRNA expression, a marker for Kupffer cells, was 3 times more abundant in 
KO hepatocytes compared to WT hepatocytes. 
 
4.5. Oxidative stress-induced DNA damage in NemoΔhepa mice 
Previous studies suggested that oxidative stress plays an important role for 
the phenotype found in the NemoΔhepa livers (Luedde, Beraza et al. 2007). However, 
Reactive Oxygen Species (ROS) can be produced from multiple sources and have 
several mediators. Superoxide anion is the primary metabolite generated through a 
one-electron reduction of molecular oxygen by a membrane-bound NADPH oxidase. 
It dismutates either spontaneously or via superoxide dismutase (SOD, MnSOD) to a 
nontoxic product dioxygen (O2) or to a less harmful product H2O2, which is further 
converted by myeloperoxydases inside lysosomes. Dihydroethidium is a marker of 
superoxide anion. It intercalates into the cell’s DNA and emits a bright red 
fluorescence upon oxidation by O2- in the nucleus.  
 We could not detect oxidative stress in control livers from Nemof/f mice (Fig. 
28) whereas NemoΔhepa showed positive cells, confirming the presence of ROS in 
those livers. 
 
Fig. 28. Dihydroethidium staining on frozen section shows oxidative stress in NemoΔhepa mice by 
emitting a red fluoresencence in the nuclei. (Red: DHE, blue: DAPI, magnification: 200x). 
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Moreover, c-Jun mRNA, a stress related molecule is highly upregulated in 
NemoΔhepa mice (Fig. 29), where a 2,2 fold induction can be observed in control 
livers, and a 3 fold induction 3h after PH compared to WT mice. 
 
Fig. 29. Real-Time PCR of whole liver extracts from Nemof/f and NemoΔhepa mice (left) and isolated 
hepatocytes from Nemof/f and NemoΔhepa mice(right) for c-Jun. White bars represent Nemof/f, black 
bars represent NemoΔhepa mice (** p< 0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]).  
Next, we analyzed other marker of ROS and inflammation (Fig. 30A), such as 
NCF1, neutrophil cytosolic factor 1 which is a 47 kDa subunit of the NADPH oxidase 
mentioned previously. Real-Time analysis revealed a 2,5 fold induction in NemoΔhepa 
livers compared to WT controls. NOS2, the inducible Nitric Oxide Synthase, was 10 
fold over expressed in KO livers. On the other hand, the manganese superoxide 
dismutase MnSOD (or mitochondrial SOD, or SOD2) was significantly down-
regulated in NemoΔhepa livers. NOS2 and MnSOD are both NF-κB target genes and 
we therefore tested if their expression would be reduced in isolated hepatocytes from 
NemoΔhepa mice. Both genes were strongly down regulated (Fig. 30B), suggesting 
that the source of NOS2 likely is the activated Kupffer cells but not the nemo deleted 
hepatocytes in our NemoΔhepa animals.  
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Fig. 30. Real-Time PCR of whole liver extracts from Nemof/f and NemoΔhepa mice (A) for NCF1, NOS2 
and MnSOD and isolated hepatocytes from Nemof/f and NemoΔhepa mice (B) for NOS2 and MnSOD. 
White bars represent Nemof/f, black bars represent NemoΔhepa mice (*** p<0.001 [Nemof/f versus 
NemoΔhepa]).  
MnSOD is needed to eliminate O2- and its low expression may also be a 
reason of higher ROS level. ROS have different negative effects on the integrity of a 
cell, one being a potent inducer of DNA damage. We analyzed the presence of 
double strand breaks in the DNA (DSBs) using the marker γH2A.X, called Histone 
H2A.X. Phospho H2A.X localizes in the nucleus upon DSBs DNA damage. We could 
detect around 1% of cells positive for pH2A.X staining in NemoΔhepa control livers 
(Fig. 31). 3h after partial hepatectomy, this number increased to 3% in KO livers, 
showing a negative effect of partial hepatectomy in NemoΔhepa livers. 
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Fig. 31. DNA damage in NemoΔhepa livers. Immunohistochemistry using a pH2A.X antibody followed by 
a FITC-labeled secondary antibody in Nemof/f and NemoΔhepa livers before and 3 hours after PH 
(Green: pH2A.X, blue: DAPI, magnification: 200x). White bars represent Nemof/f, black bars represent 
NemoΔhepa mice (*** p<0.001 [Nemof/f versus NemoΔhepa]). 
The p53-induced cell cycle inhibitor p21 can either mediate cell cycle arrest if 
the DNA is damaged and susceptible to repair, or mediate apoptosis in case of 
irreversible damage. P21 was strongly induced in NemoΔhepa at all the time points 
analyzed by Western blot (Fig. 32), while its expression was low in untreated WT 
livers and slightly up regulated 1 and 3 hours after PH. On the contrary, GADD45α 
was strongly reduced in KO livers at all time points compared to WT level expression.  
GADD45α is widely expressed in normal tissues and is involved in DNA repair 
mechanism (Hollander, Sheikh et al. 1999). It is induced by the transcription factor 
NF-κB, which could explain the low expression found in Nemo KO mice.  
 
Fig. 32. Western Blot analysis of whole liver extracts of Nemof/f and NemoΔhepa animals for p21 and 
GADD45α before and after PH. GAPDH was used as loading control. 
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4.6. Increased liver damage in NemoΔhepa mice after partial 
hepatectomy 
 Hematoxylin & Eosin (H&E) staining is the most prominent technique to study 
liver histology. The staining was performed by the Department of Pathology from the 
University Hospital. Technically, the basic dye hematoxylin colors basophilic 
structures like nucleic acids (RNA, DNA), ribosomes and chromatin in deep blue 
while eosinophilic such as proteins or red blood cells are stained in red, like most of 
the cytoplasm. H&E staining from WT livers at different time points showed a normal 
regeneration after 15d, with hyperplasia of the remaining lobes (Fig. 33 upper 
panels). On the contrary, livers form NemoΔhepa animals presented a great 
heterogeneity depending on the time point analyzed. Control livers from Nemo KO 
mice showed large hepatocytes with big nuclei, mitotic figures confirming the non-
quiescent state of these livers, strong infiltration of immune cells and presence of 
ovoid cells, very likely oval cells. 6h post hepatectomy, the cellularity (number of cells 
per power field) increased, meaning that there are more cells in each analyzed fields, 
with a strong amplification of oval cells, correlating with the CK19 data. Two weeks 
after surgery, the liver depicted strong signals of oval cells and immune cells 
infiltration (Fig. 33 lower panels). 
 
Fig. 33. H&E staining of paraffin liver section from Nemof/f (upper panels) and NemoΔhepa (lower 
panels) mice before and after partial hepatectomy (magnification: 200x). 
Aspartate amino transferase (AST) and Alanine amino transferase (ALT) are 
enzymes released into the blood when certain cell types are damaged. ALT is liver 
specific while AST can be found in other tissues e.g. the heart. After partial 
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hepatectomy, transaminases rise in the first 24h post surgery and then return to 
normal levels (Fig. 35). NemoΔhepa mice have elevated AST and ALT levels per se 
and after partial hepatectomy, both enzymes’ activity were significantly higher 
compared to WT livers. 15d after liver resection, transaminases level returned to 
values found in untreated animals, similar to the WT kinetic.  
 
 
Fig. 35. Transaminases serum level before and during liver regeneration in Nemof/f and NemoΔhepa 
animals. White bars represent Nemof/f, black bars represent NemoΔhepa mice (* p<0.05; ** p< 0.01; *** 
p<0.001 [Nemof/f versus NemoΔhepa]). 
 
4.7. Liver phenotype in NemoΔhepa mice at late time points after 
partial hepatectomy 
After 70% partial hepatectomy, liver regeneration is complete within two 
weeks. Taking into account that in NemoΔhepa mice hepatocyte proliferation could be 
observed at day 15 after PH, we aimed to investigate the consequences of PH in 
these KO animals at longer time points. We thus studied mice 2 months after partial 
hepatectomy. At this time point, WT livers did not significantly differ from WT sham 
operated animals in H&E stainings, showing small hepatocytes hyperplasia (Fig. 36A, 
upper panels). On the other hand, sham operated NemoΔhepa mice developed 
steatohepatitis with age (Fig. 36A, lower panels). We could already observe in 17 
weeks old mice (8 weeks + 2 months=17 weeks) macro- and micro-vesicular lipid 
storage in the liver. On the contrary, KO livers after hepatectomy looked different. 
The cellularity was increased, the cells were normalized with a large cytoplasm and a 
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small nucleus. Infiltration of immune cells was still detectable but the number of cells 
was lower and lipid storage was much reduced compared to sham-treated NemoΔhepa 
animals. 
 
Fig. 36. H&E staining on partial hepatectomized or sham treated livers Nemof/f and NemoΔhepa mice 2 
months after surgery. B. CK19 staining on Nemof/f and NemoΔhepa mice (red, CK19-positive cells; blue, 
DAPI-stained nuclei. Magnification: 200x). 
Besides the improved liver parenchyma observed in NemoΔhepa mice 2 months 
after partial hepatectomy, CK19 staining was very different compared to a normal 
Nemo KO liver. No oval cells could be detected, just cholangiocytes (epithelial cells 
of the bile duct) which also share this marker, but have a very specific intracellular 
localization (Fig. 36B). These surprising results led to the hypothesis that during liver 
regeneration in NemoΔhepa mice, the strong and fast oval cell reaction could 
repopulate the liver and differentiate into immature hepatocytes. Real-Time PCR 
analysis of whole liver extract revealed decreased Cre mRNA expression in the 2 
months PH group of  the NemoΔhepa mice (Fig. 37A). Moreover, Nemo mRNA level 
was significantly higher in the 2 months group compared to control or 6h PH group, 
almost reaching WT levels (Fig. 37B). The TRAIL receptor-2 DR-5 which expression 
is up regulated upon bile acids and fatty acids is considered as a marker of liver 
damage in the NemoΔhepa mice (Beraza, Malato et al. 2009). DR-5 mRNA level was 
also significantly reduced in Nemo mice 2 months after PH compared to KO control 
(Fig. 37C). 
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Fig. 37. Real-Time PCR of whole liver extracts for Cre (A), Nemo (B) and DR-5 (C) from Nemof/f and 
NemoΔhepa mice. White bars represent Nemof/f, black bars represent NemoΔhepa mice (* p<0.05; ** p< 
0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]; §§§ p<0,001 [NemoΔhepa control versus NemoΔhepa 
hepatectomized livers]). 
 
4.8. Partial hepatectomy leads to counter selection of Cre negative 
oval cells 
Based on the massive lethality observed in NemoΔhepa mice after PH and 
considering our data, we hypothesized that an additional counter selection process 
may occur in NemoΔhepa livers. The Cre recombinase construct is activated in cells 
expressing albumin, which are mostly hepatocytes. However, some cholangiocytes 
may also express Cre because they marginally express albumin and AFP, and 
therefore nemo could be deleted. The same is true for oval cells, since they slightly 
express albumin and nemo could be already deleted. To test this hypothesis, we had 
to elaborate a strategy to select oval cells. We used the MACS system (MAgnetic 
Cell Sorting) with the SCA-1 antibody a putative marker of liver stem cells (Petersen, 
Grossbard et al. 2003). In order to harvest a fair amount of oval cells in the liver, we 
used the DDC (3,5-diethoxycarbonyl-1,4-dihydro-collidine) diet model which has been 
described to induce oval cell proliferation. 
We analyzed the non-parenchymal cell fraction by FACS analysis, to define 
the population which should contain oval cells/stem cells (Petersen, Grossbard et al. 
2003; Wang, Foster et al. 2003). Double staining of the non-parenchymal cell 
population for c-Kit PE and SCA1 PE-Cy7 revealed that the c-Kit positive cells were 
also 100% SCA1 positive (Fig. 38). These results validate our isolation strategy to 
obtain pure liver oval cells.  
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Fig. 38. FACS analysis of liver stem cells. CD45+/c-kit+ cells are SCA1+ cells. 
 Magnetic sorting is an efficient tool to separate cells, however the purity of the 
sorted cells has to be assessed. After sorting the cells, we analyzed the two 
population that we obtained from the sorting experiment, the SCA1 negative and 
positive cells. SCA1 MACS antibody is FITC labeled so the SCA1 positive cells can 
be analyzed by FACS. We obtained 9% of SCA1 positive cells in the SCA1 negative 
population for both WT and KO livers (Fig. 39) while the SCA1 positive population 
showed 70% of purity for both genotypes.  
 
 
 
Fig. 39. Determination of purity after MACS sorting of liver stem cells by FACS analysis  
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After sorting the cells, we isolated mRNA from SCA1 negative and positive 
populations to analyze mRNA expression of various selected genes. Sca1 mRNA 
expression was very low in NemoΔhepa hepatocytes, as well as in SCA1 negative cells 
as expected while it was strongly expressed in SCA1 positive cells. Cre mRNA 
expression was high in NemoΔhepa hepatocytes, cells which are effectively expressing 
Cre recombinase, as an internal positive control. SCA1 negative cells had an 
expression as low as 4% when Cre+ hepatocytes are set to be the reference. On the 
other hand, SCA1 positive cells had a higher expression of 18% compared to the 
Cre+ hepatocytes, showing that some oval cells show already a deletion for nemo 
(Fig. 40). 
 
Fig. 40. Real-Time PCR of different liver cell populations from NemoΔhepa mice (§§ p<0,01; §§§ p<0,001 
[NemoΔhepa reference cells versus NemoΔhepa sample cells]). 
 We next analyzed the SCA1 positive cells isolated 1 month after partial 
hepatectomy. SCA1 positive cells from NemoΔhepa control mice served as our 
reference and SCA1 cells 1 month after hepatectomy showed significantly less Cre 
expression, in both condition, with or without DDC feeding (Fig. 41A). Additionally, 
Nemo expression was significantly higher in the same samples compared to our 
SCA1+ control cells (Fig. 41B). These data support the hypothesis that after partial 
hepatectomy, a strong selection of non expressing Cre stem cells occurred in 
NemoΔhepa livers. 
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Fig. 41. Real-Time PCR for Cre (A) and Nemo (B) of different liver cell populations from NemoΔhepa 
mice (§§§ p<0,001 [NemoΔhepa control versus NemoΔhepa hepatectomized livers]). 
 
4.9. 3,5-dicarbethoxy-1,4-dihydrocollidine diet model (DDC) in 
NemoΔhepa mice 
The cholestatic phenotype of the DDC model and its underlying pathobiology 
has only recently been elucidated in more detail (Fickert, Stoger et al. 2007). DDC 
feeding induces sclerosing cholangitis and a biliary type of liver fibrosis. This involves 
the secretion of pro-inflammatory mediators and cytokines such as TNF-α, IL-6 
(Subrata, Lowes et al. 2005) and the activation of profibrogenic factors such as 
PDGF and TGFβ (Nguyen, Furuya et al. 2007). Together with an increased biliary 
porphyrin secretion this leads to an activation of biliary epithelial cells which induces 
a significant pericholangitis. As a consequence the secretion of toxic metabolites is 
impaired, and further triggers hepatocyte injury and inhibits tissue repair. 
Additionally, DDC feeding activates the intrahepatic stem cell compartment. Oval 
cells are induced and start to proliferate mainly because hepatocytes are unable to 
enter the cell cycle. 
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Fig. 42. H&E staining (A, B) CK19 staining (C, D) and Ki67 staining (E, F) on DDC fed Nemof/f and 
NemoΔhepa mice (magnification: 200x).  
We fed Nemof/f and NemoΔhepa mice for 4 weeks with DDC diet and after 
sacrificing the mice we performed H&E staining. Livers taken from DDC fed mice are 
extremely dark compared to normal livers macroscopically. This is demonstrated by 
the H&E staining where we can observe the heme “breakdown” accumulation 
(Petersen, Grossbard et al. 2003; Wang, Foster et al. 2003), which causes the dark 
red color to the liver of DDC fed mice. In addition we observed a strong periportal 
accumulation and clustering of morphologically small appearing cells with small 
cytoplasm (Fig. 42A, B). Additionally, small duct like structures were formed in 
periportal areas which were more prominent in NemoΔhepa livers. CK19 staining was 
stronger in NemoΔhepa mice compared to Nemof/f (Fig. 42C, D). This result was further 
confirmed by analyzing the fluorescence intensity (Fig. 43) which was three times 
increased in the Nemo KO livers. Finally, Ki67 did not show any significant difference 
between WT and Nemo KO mice (Fig. 42 E, F and Fig. 43). 
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Fig. 43. Quantification of total CK19 fluorescence intensity using Image J software per x200 power 
field (left Y axis) and Ki67 quantification (right Y axis). White bars represent Nemof/f, black bars 
represent NemoΔhepa mice (*** p<0.001 [Nemof/f versus NemoΔhepa]).  
 
4.10. Higher liver damage in NemoΔhepa DDC fed mice 
Serum parameters showed a strong liver damage in Nemof/f mice as illustrated 
by an elevated AST and ALT level compared to non-fed Nemof/f. Also in NemoΔhepa 
mice, liver damage was greater in the DDC fed mice compared to animals fed with a 
control diet (Fig. 44A, B). A striking feature of the serum was the bright yellow color, 
indicating increased bilirubin levels. Bilirubin metabolism begins with the breakdown 
of red blood cells in many parts of the body. Red blood cells contain hemoglobin, 
which is broken down to heme and globin. Heme is converted to bilirubin, which is 
then carried by albumin in the blood to the liver. Serum bilirubin is considered a true 
test of liver function, as it reflects the liver's ability to take up, process, and secrete 
bilirubin into the bile. 
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Fig. 44. AST (A), ALT (B) and bilirubin (C) serum level in Nemof/f and NemoΔhepa animals fed with chow 
diet or DDC diet. White bars represent Nemof/f chow diet, black bars represent NemoΔhepa mice chow 
diet, vertical stripes represent Nemof/f DDC diet horizontal stripes represent NemoΔhepa DDC diet (* 
p<0.05; ** p< 0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]; §§§ p<0,001 [NemoΔhepa chow diet versus 
NemoΔhepa DDC diet]). 
Total Bilirubin is very low in serum from non-fed animals and is therefore 
undetectable by the serum analyzer. However after DDC diet, it is increased and it is 
significantly higher in NemoΔhepa mice compared to Nemof/f mice (Fig. 44C). It is also 
noticeable that the skin of KO animals is yellowish after DDC diet, reflecting jaundice. 
 Liver hepatomegaly is also a characteristic of DDC feeding. The liver size is 
doubled compared to a normal liver (Fig. 45A) and in contrast to mice fed with chow 
diet, NemoΔhepa livers after DDC feeding are significantly bigger compared to a 
similarly Nemof/f treated livers. One month after partial hepatectomy complete 
restoration of liver mass in DDC hepatectomized animals was found and no 
difference could be detected between both genotypes (Fig. 45B). 
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Fig. 45. Liver weight/Body weight ratio on DDC fed mice, before (A) and 1 month after PH (B). White 
bars represent Nemof/f chow diet, black bars represent NemoΔhepa mice chow diet, vertical stripes 
represent Nemof/f DDC diet horizontal stripes represent NemoΔhepa DDC diet (* p<0.05; ** p< 0.01; *** 
p<0.001 [Nemof/f versus NemoΔhepa]; §§§ p<0,001 [NemoΔhepa chow diet versus NemoΔhepa DDC diet]). 
 
4.11. Pre-oval cell expansion improves the survival of NemoΔhepa 
mice after partial hepatectomy 
 From our PH experiments in NemoΔhepa mice, we developed the hypothesis 
that liver regeneration is impaired in these animals due to a defect in hepatocyte 
proliferation. However oval cells are partially able to substitute this defect. Therefore 
expanding the pool of oval cells in NemoΔhepa livers could further improve liver 
regeneration in these animals. 
 We thus fed NemoΔhepa mice for 4 weeks with DDC diet and performed partial 
hepatectomy and monitored the survival of the mice. Surprisingly, similar results were 
obtained for both genotypes with a survival percentage of 80% which was 
significantly better for NemoΔhepa mice, but also significantly worse for Nemof/f 
animals (Fig. 46). These results confirm the important role of oval cells for the 
impaired regenerative response in NemoΔhepa mice after PH.  
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Fig. 46. Kaplan-Meier curve of surviving mice after partial hepatectomy on DDC fed animals. Dashed 
lines represent Nemof/f, solid lines represent NemoΔhepa mice. 
 
4.12. Modulating oxidative stress in mice 
 Based on previous studies and our own data, we hypothesized that 
modulating the oxidative level in NemoΔhepa could play an important role in the 
phenotype observed in these mice, before and after partial hepatectomy. Luedde et 
al. improved the phenotype and also prevented steatosis after Butylated 
Hydroxyanisole diet (BHA) in NemoΔhepa mice. BHA is an antioxidant consisting of a 
mixture of two isomeric organic compounds, 2-tert-butyl-4-hydroxyanisole and 3-tert-
butyl-4-hydroxyanisole. It is a waxy solid used in certain amounts as a food additive 
with the E number E320. The conjugated aromatic ring of BHA is able to stabilize free 
radicals by sequestering them. By acting as free radical scavengers, further free 
radical reactions are prevented. 
 
Annexe 9. Structure of Butylated Hydroxyanisole (BHA) 
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Phenethyl isothiocyanate (PEITC) is a natural compound found in cruciferous 
vegetables (Brassicaceae) which can rapidly conjugate with Glutathione (GSH). This 
causes a depletion of the GSH pool and subsequently increases oxidative stress and 
cell death (Trachootham, Alexandre et al. 2009). 
 
Annexe 10. Structure of Phenethyl isothiocyanate (PEITC) 
In the present study we used BHA antioxidant diet to reduce oxidative stress 
and alternatively PEITC injections to increase Reactive Oxygen Species (ROS) level 
in the liver. 
 
4.13. Oxidative stress level determines the outcome of NemoΔhepa 
mice after partial hepatectomy 
 As previously shown, NemoΔhepa have higher serum transaminases. After BHA 
feeding for 4 weeks, we found a significant reduction of transaminases in NemoΔhepa 
mice compared to chow diet fed animals (Fig. 47A, B). Surprisingly, we found a 
similar result after one week of treatment with the ROS inducer PEITC.  
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Fig. 47. Transaminases serum level in Nemof/f and NemoΔhepa under various conditions. AST (A), ALT 
(B) (* p<0.05; ** p< 0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]; §§§ p<0,001 [NemoΔhepa chow diet 
versus NemoΔhepa treated]). 
Interestingly, we found profound disparities after partial hepatectomy within 
these two groups. The BHA KO group showed the same level of liver damage as 
non-fed WT mice 3h after PH. At the same time point, the PEITC group displayed 
similar damage as the chow-diet fed NemoΔhepa group 3h after PH (Fig. 48A, B). 
Calculating the difference between AST levels in non operated mice and 3h after 
partial hepatectomy, the “Delta AST”, showed a much bigger difference in the PEITC 
treated KO mice compared to chow diet KO mice (Fig. 49). 
 
Fig. 48. Blood parameters AST (A) and ALT (B) 3h after partial hepatectomy following oxidative stress 
modulation. White bars represent Nemof/f chow diet, black bars represent NemoΔhepa mice chow diet, 
grid bars represent NemoΔhepa mice BHA diet, slanting stripes bars represent NemoΔhepa mice PEITC (* 
p<0.05; ** p< 0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]; §§§ p<0,001 [NemoΔhepa chow diet versus 
NemoΔhepa treated]). 
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Fig. 49. AST difference between 3h post hepatectomy and control (non-operated) values in Nemof/f 
and NemoΔhepa following oxidative stress modulation. 
 In the BHA group, H&E staining showed a reduction of infiltrating cells, of 
mitotic figures and smaller hepatocytes, confirming the improved phenotype (Fig. 49). 
In contrast, the PEITC group did not display any dramatic improvement which could 
explain the reduction in transaminases in control livers. 3h after PH, the control (chow 
fed) NemoΔhepa group and the PEITC group exhibited a high number of infiltrating 
cells, albeit with a different pattern. It was more spread in the normal KO contrasting 
to the agglomerates found in PEITC treated NemoΔhepa livers. 
 
Fig. 49. H&E staining of normal, BHA fed and PEITC NemoΔhepa livers. Upper panels, controls livers. 
Lower panels, livers 3h after PH (magnification: 200x).  
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 Next we tried to determine the impact of oxidative stress modulation on the 
survival after partial hepatectomy. All mice fed with BHA diet survived surgery, 
regardless of the genotype, representing a striking difference compared to 50% of 
survival found in untreated NemoΔhepa mice (Fig. 50). In the PEITC-treated groups, 
we found major differences. 70% of WT mice died after surgery, giving an average 
median survival of 77h whereas 100% of the NemoΔhepa mice died within 70h which 
represents an average median survival of 40h, a number significantly lower 
compared to WT mice. These data suggest that the oxidative stress level is crucial 
for the outcome of Nemo KO mice after PH. 
 
Fig. 50. Kaplan-Meier curve of surviving mice after partial hepatectomy on BHA fed and PEITC 
injected animals. Orange-dashed lines represent Nemof/f BHA, blue-dashed lines represent NemoΔhepa 
mice BHA. Grey dashed lines represent Nemof/f PEITC and black-dashed lines represent NemoΔhepa 
mice PEITC (** p< 0.01; [Nemof/f PEITC versus NemoΔhepa PEITC]. 
 
 In the present study, we have shown (Fig. 31) that NemoΔhepa had double 
strand breaks (DSBs) DNA damage in control livers which was further increased after 
PH. After BHA feeding, pH2A.X was almost completely negative before and 3h after 
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PH (Fig. 51), which after quantification was 5 times lower compared to chow-fed 
animals. Additionally, after PEITC injection, pH2A.X staining was significantly 
increased in control livers compared to non treated control liver. 3h after PH, the 
amount of pH2A.X positive cells remains constant in the PEITC group in contrast to 
the non-treated mice where a three fold increase was detected. 
 
 
Fig. 51. (A) pH2A.X staining on frozen section to show DSBs DNA damage (green: pH2A.X, blue: 
DAPI, magnification: 200x). and (B) pH2A.X quantification. Black bars represent NemoΔhepa mice chow 
diet, grid bars represent NemoΔhepa mice BHA diet, slanting stripes bars represent NemoΔhepa mice 
PEITC (§ p<0,05; §§ p<0,01; §§§ p<0,001 [NemoΔhepa chow versus NemoΔhepa treated]). 
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4.14. The cellular redox homeostasis is altered in NemoΔhepa mice 
In order to investigate the mechanisms underlying the generation of ROS, we 
analyzed oxidative stress markers by Real-Time PCR after modulating the oxidative 
stress level in NemoΔhepa mice. Besides the Nemof/f which served as reference, we 
had 3 groups of NemoΔhepa mice, untreated (chow-fed), BHA and PEITC. Compared 
to untreated Nemo KO, NCF1 mRNA expression was significantly reduced in the 
BHA group, almost reaching WT levels (Fig. 52A). On the opposite, the PEITC group 
showed a significant increase in NCF1 mRNA expression compared to untreated KO 
mice. Sestrin3 was strongly down regulated in the BHA fed mice while it was slightly 
up regulated in the PEITC injected mice compared to the untreated KO control mice. 
C-Jun mRNA levels were significantly higher in the PEITC group compared to the 
normal group whereas the BHA group was significantly reduced, reaching WT levels. 
MnSOD mRNA levels in BHA group was not significantly different to WT animals 
while MnSOD expression in the PEITC mice was significantly decreased compared 
to the untreated KO group. 
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Fig. 52. Real-Time PCR of whole liver extracts for NCF-1, Sestrin 3, c-Jun and MnSOD (A) and NOS2 
and Cyclin D (B). White bars represent Nemof/f chow diet, black bars represent NemoΔhepa mice chow 
diet, grid bars represent NemoΔhepa mice BHA diet, slanting stripes bars represent NemoΔhepa mice 
PEITC (* p<0.05; ** p< 0.01; *** p<0.001 [Nemof/f versus NemoΔhepa]; § p<0,05; §§ p<0,01; §§§ 
p<0,001 [NemoΔhepa chow versus NemoΔhepa treated]). 
Finally, NOS2 and Cyclin D mRNA levels were significantly higher in the 
PEITC and significantly lower in the BHA group compared to untreated NemoΔhepa 
mice (Fig. 52B). 
Western Blot analysis confirmed the higher oxidative stress found in the 
PEITC group. NOS2 expression was significantly higher before and 3h after PH in 
the PEITC-treated KO mice compared to WT, chow diet NemoΔhepa and the BHA 
NemoΔhepa mice groups (Fig. 53). Moreover pJNK could be already detected in 
PEITC-treated NemoΔhepa mice without PH, while it was negative in all the other 
control groups. Phospho JNK protein level was detectable 3h after PH in untreated 
NemoΔhepa mice but the expression was more prominent in the PEITC group, 
confirming a strong effect of PH on oxidative stress. The expression of the cell cycle 
inhibitor p21 was dramatically increased in the BHA group before and after PH. As 
shown previously (Fig. 32), NemoΔhepa mice have a strong p21 expression in 
comparison to the WT levels. However, the cell cycle is not blocked in those animals 
(Fig. 20A, B). In the BHA group, p21 over expression could have a stronger impact 
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on the cell cycle. Bcl-2 is an anti-apoptotic protein located in the mitochondrial 
membranes. Western-Blot analysis revealed a strong down regulation of Bcl-2 in 
chow diet NemoΔhepa and PEITC group while the expression is strong in the BHA 
group, with levels comparable to the WT group. This result could reflect the 
noticeable improvement described in the mitochondria of NemoΔhepa mice fed with 
BHA diet (Luedde, Beraza et al. 2007). 
 
Fig. 53. Western Blot analysis on whole liver extracts for NOS2, pJNK, p21 and Bcl2 in Nemof/f, 
NemoΔhepa chow diet, NemoΔhepa BHA diet and NemoΔhepa PEITC mice. GAPDH was used as a loading 
control.  
 
4.15. Oxidative stress triggers liver regeneration and oval cell 
expansion 
Ki67 is a marker of proliferating cells, although it is not phase specific like 
BrdU. As previously shown, hepatocytes of NemoΔhepa mice proliferate per se (Fig. 
18, Fig. 54). After PEITC treatment, Ki67 staining exhibited significantly more positive 
cells compared to normal NemoΔhepa animals (Fig. 20A, B). In contrast, the staining 
was almost negative in BHA fed mice. Significant changes occurred 48h after PH 
where the BHA group displayed a Ki67 staining similar to Nemof/f after PH. 
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Quantification (Fig. 55A) of the proliferation index was similar in these two groups 
which were significantly different to the value we obtained from the chow diet fed 
NemoΔhepa mice. However we could not collect any samples from PEITC treated 
NemoΔhepa mice 48h after PH due to their high mortality after PH. We thus analyzed 
samples 24h after surgery (Fig. 55A). Here a significant reduction of Ki67 positive 
cells compared to non-operated PEITC was found, most likely due to the general liver 
failure leading to death in those animals. 
 
Fig. 54. Immunohistochemistry using Ki67 antibody followed by a Cy3-labeled secondary antibody on 
frozen section to show proliferative cells in the liver (Red: Ki67, blue: DAPI, magnification: 200x). 
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Fig. 55. Ki67 quantification A and B. White bars represent Nemof/f chow diet, black bars represent 
NemoΔhepa mice chow diet, grid bars represent NemoΔhepa mice BHA diet, slanting stripes bars 
represent NemoΔhepa mice PEITC (* p<0.05; *** p<0.001 [Nemof/f versus NemoΔhepa]; §§§ p<0,001 
[NemoΔhepa chow versus NemoΔhepa treated]). 
Besides hepatocytes which were proliferating in control NemoΔhepa livers, 
CK19 positive cells seemed to play a role in those mice as shown in Fig. 21. CK19 
staining was greatly reduced in BHA control livers while it was significantly increased 
in the PEITC control livers compared to normal NemoΔhepa mice (Fig. 56). We then 
analyzed the samples collected 3h after PH and we could already detect an 
expansion of CK19 positive cells in the NemoΔhepa mice. The BHA and the PEITC-
treated groups 3h after PH showed no increased CK19 expression over their 
respective controls. Two days after PH, during the peak of proliferation, the chow diet 
fed KO group exhibited a slight increase CK19 expression over the 3h, whereas the 
BHA-treated group remained significantly lower. 
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Fig. 56. Immunohistochemistry using CK19 antibody followed by a Cy3-labeled secondary antibody on 
frozen section (upper panel, red and green: CH19, blue: DAPI, magnification: 200x).) and CK19 
quantification (lower panel). Black bars represent NemoΔhepa mice chow diet, grid bars represent 
NemoΔhepa mice BHA diet, slanting stripes bars represent NemoΔhepa mice PEITC (§ p<0,05; §§ 
p<0,01; §§§ p<0,001 [NemoΔhepa chow versus NemoΔhepa treated]). 
Due to the high mortality of PEITC treated animals, we analyzed the liver 
samples obtained only 24 hours after PH. Examination of the 24h PEITC samples 
revealed a staining similar to the 3h or control PEITC group. 
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4.16. Survival of NemoΔhepa mice after partial hepatectomy depends 
on oval cell activation and the oxidative stress status in the liver 
 In summary, after analyzing all our results it seems obvious that the level of 
oxidative stress in NemoΔhepa animals determines the outcome after partial 
hepatectomy. As shown in figure 57, the best outcome for the KO mice was obtained 
with the antioxidant BHA diet resulting in 100% survival. Interestingly, DDC diet also 
improved the outcome (80% of survival, comparable with the WT group) despite the 
toxicity of the food, compared to the chow diet fed NemoΔhepa (50% of surviving 
mice). These results highlight the essential role of oval cells for liver regeneration of 
NemoΔhepa animals. In clear contrast, mice with higher ROS production after PEITC 
treatment had a deleterious outcome as all animals died within 70h after partial 
hepatectomy. 
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Fig. 57. Kaplan-Meier curve of surviving mice after partial hepatectomy on DDC, BHA fed and PEITC 
injected animals. Dashed dark grey lines represent Nemof/f, black solid line represents NemoΔhepa mice 
(*** p<0.001 [Nemof/f versus NemoΔhepa]). Green-dashed lines represent Nemof/f DDC, brown-dashed 
lines represent NemoΔhepa DDC. Orange-dashed lines represent Nemof/f BHA, blue-dashed lines 
represent NemoΔhepa mice BHA. Grey-dashed lines represent Nemof/f PEITC and black-dashed lines 
represent NemoΔhepa mice PEITC (** p<0.01 [Nemof/f PEITC versus NemoΔhepa PEITC]). 
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5. Discussion 
 
Hepatocyte-specific IKK2 deletion triggers the innate immune 
response and promotes earlier cell proliferation during liver 
regeneration 
 
NF-κB is an essential transcription factor to maintain liver homeostasis (Karin 
and Lin 2002; Luedde, Beraza et al. 2007). Additionally, knockout mice of members 
of the IKK complex controlling NF-κB activation die from hepatocyte apoptosis during 
embryonal development (Tanaka, Fuentes et al. 1999; Rudolph, Yeh et al. 2000). 
Thus the complex regulation between the different factors involved in this pathway is 
of central relevance for the liver. In the first part, we used hepatocyte-specific IKK2 
knockout mice to further elucidate the role of the IKK complex during liver 
regeneration. 
After PH in IKK2Δhepa mice major differences in NF-κB activation were found 
compared to WT IKK2f/f animals. In WT mice NF-κB activation was first found in 
hepatocytes, while in IKK2Δhepa animals p65 was first positive in non-parenchymal 
liver cells (NPC), resulting in a stronger inflammatory response. In our previous study 
using IKK2Δhepa animals the inflammatory response after I/R injury was attenuated 
compared to WT controls (Luedde, Assmus et al. 2005). Both studies show that IKK2 
expression in hepatocytes is essential to direct the crosstalk between hepatocytes 
and NPC in a stimulus dependent manner during inflammation, which is of major 
relevance for liver physiology. However at present, the intercellular crosstalk between 
IKK2 deficient hepatocytes and NPCs during liver regeneration is not fully 
understood.  
Analysis of the IKK complex activity revealed that IKK2Δhepa mice showed 
stronger IKK1 activation after PH despite later p-IκB-α expression that correlated with 
a delayed kinetic of p65 activation in hepatocytes. A potential explanation for the 
stronger IKK1 activation observed could be that lack of IKK2 protein expression 
results in increased activation (phosphorylation) of IKK1 and consequently, enhanced 
signaling via the non-canonical pathway in IKK2Δhepa mice after PH. At present the 
role of IKK1 during liver regeneration has not been studied. However, knockout mice 
for typical IKK1 activators, like Lymphotoxin-α (LTα) and its receptor (LTβR), show 
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impaired liver regeneration after PH (Anders, Subudhi et al. 2005) pointing to the 
relevance of the non-canonical pathway during liver regeneration. Moreover, we 
cannot exclude that signaling via the non-canonical pathway in IKK2Δhepa mice may 
cooperate in the production of ligands that activate NPCs, contributing to the 
crosstalk between cell compartments after PH (Bonizzi, Bebien et al. 2004).  
In order to further test the relevance of IKK2 for the crosstalk between 
hepatocytes and NPC we used the IKK2 inhibitor AS602868 to systemically block 
IKK2 activation during liver regeneration. Interestingly, inhibition of IKK2 in all cell 
compartments did not significantly alter DNA synthesis after PH. Earlier results 
demonstrated that IKK2 inhibition in myeloid cells blocks NF-κB activation (Arkan, 
Hevener et al. 2005) and that using AS602868 the inflammatory response is also 
blocked in NPCs in the liver (Beraza, Malato et al. 2008). This, together with our 
present data suggests that AS602868 administration during PH also reduces the 
inflammatory response in NPCs which reverts the proliferative advantage shown in 
IKK2Δhepa mice. 
Our results using IKK2Δhepa mice cannot be compared to previous experiments 
using either an adenoviral IκB super repressor or transgenic mice carrying an 
inducible IκB mutant in hepatocytes (Iimuro, Nishiura et al. 1998; Chaisson, Brooling 
et al. 2002). Both approaches blocked NF-κB activation downstream of the IKK 
complex, however the outcome of these studies was different as apoptosis and 
impaired hepatocyte proliferation were found when the adenoviral vector was applied 
(Iimuro, Nishiura et al. 1998), while no significant effects on liver regeneration were 
observed using transgenic mice carrying the inducible IκBα mutant (Chaisson, 
Brooling et al. 2002). In the Chaisson study NF-κB is blocked and not delayed as 
found in our study. This difference between the two studies might also contribute to 
the observation why the imbalance in NF-κB activation as found in IKK2Δhepa mice 
triggers the strong inflammatory response in the NPC compartment. 
 
We here show that earlier NF-κB activation in the NPC compartment observed 
in mice lacking IKK2 correlated with a rapid and strong inflammatory response. 
Polimorphonuclear cells (neutrophils) have different roles depending on the type of 
damage as they can contribute to liver injury or display beneficial effects by mediating 
resolution of wound healing, tissue repair and cell proliferation (Engelhardt, Toksoy et 
al. 1998; Hogaboam, Bone-Larson et al. 1999). Targeting immune cells to the 
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damaged tissue relies on the production of chemo-attractants. ELR+CXC 
chemokines mediate chemotaxis of neutrophils. After PH, higher expression of 
CXCL1 in IKK2Δhepa mice correlated with a faster mobilization of neutrophils and 
recruitment to the liver that may contribute to earlier hepatocyte proliferation in 
IKK2Δhepa mice as ELR+CXC chemokines contribute to liver regeneration after 
acetaminophen-induced injury (Hogaboam, Bone-Larson et al. 1999) . 
In order to elucidate the molecular mechanism by which ELR+ chemokines are 
more rapidly induced in the liver of IKK2Δhepa mice we studied the activation of 
relevant signaling pathways, namely the STAT3- pathway in WT and IKK2Δhepa mice 
after PH. We have previously demonstrated that hepatocytes are a potent source of 
CXCL1, which is strongly induced in response to gp130/STAT3 signaling (Klein, 
Wustefeld et al. 2005). Levels of the gp130 ligand IL-6 and pSTAT3 were equal in the 
two groups. However, there are evidences that the JAK/STAT-3 and NF-κB pathways 
communicate (Zhang and Fuller 1997; Hagihara, Nishikawa et al. 2005) – in an IKK2-
dependent fashion (Albrecht, Yang et al. 2007). We therefore propose that increased 
CXCL-1 levels observed in IKK2Δhepa mice after PH are a result of disrupted inhibition 
of STAT-3 by IKK2. This is further supported by enhanced SAA transcription in 
IKK2Δhepa mice as SAA gene expression is tightly controlled by gp130/STAT3. The 
interaction of both STAT-3 and NF-κB has both synergistic and inhibitory 
consequences during acute phase genes transcription as they share binding sites in 
the promoters of these genes, rendering enhanced or competitive overlapping 
interactions (Zhang and Fuller 1997; Hagihara, Nishikawa et al. 2005; Albrecht, Yang 
et al. 2007). Thus, it is very likely that despite comparable IL-6 production and STAT-
3 phosphorylation after PH, IKK2Δhepa mice exhibit earlier, stronger and sustained 
SAA production than WT littermates due to the lower presence of competitive NF-κB, 
allowing more efficient STAT-3 binding to the SAA promoter in hepatocytes.   
Additionally, we investigated the degree of ECM degradation in the liver, since 
this promotes the bioavailability of growth factors such as HGF (Olle, Ren et al. 2006) 
and contributes to leukocyte extravasation during the inflammatory response 
(Khandoga, Kessler et al. 2006). MMP-9 is a TNF inducible molecule (Serandour, 
Loyer et al. 2005) that plays a key role in ECM degradation and deficient mice exhibit 
slower and delayed hepatocyte proliferation (Olle, Ren et al. 2006). In consonance, 
we found that enhanced TNF expression in livers of hepatocyte-IKK2 deleted mice 
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correlated with earlier MMP-9 activity, which all together could contribute to earlier 
priming as observed in IKK2Δhepa mice. 
These results correlated with prolonged JNK activation, a known target of TNF 
that can be negatively regulated by NF-κB (Tang, Minemoto et al. 2001), and earlier 
c-myc expression in livers of IKK2Δhepa mice after PH. Both pathways are directly 
involved to translate stronger stimulation via extracellular stimuli into earlier cell cycle 
progression. As e.g. Cyclin D is a direct target gene of JNK/AP-1 signaling these 
results provide the molecular link between the stronger inflammatory response and 
earlier G1/S-phase transition in IKK2Δhepa mice (Schwabe, Bradham et al. 2003). 
During mitosis, differences were found between IKK2Δhepa and WT animals. While 
Cyclin B levels peaked at the same time point, exit of mitosis was prolonged in 
IKK2Δhepa animals as evidenced by longer Histone H3 phosphorylation and delayed 
ECM degradation. At present we have no obvious explanation for this observation. 
However, these differences could either be a direct effect of lack of IKK2 expression 
in hepatocytes or a consequence of impaired synchronization during earlier time 
points of hepatocyte proliferation in IKK2Δhepa animals. 
 
The present work contributes essentially to the understanding of the role of 
IKK2 and consequently NF-κB signaling in injury induced liver regeneration. 
Additionally, it highlights the relevance of NPC and their crosstalk with hepatocytes 
during this process and supports our previous work depicting the importance of 
preserving the balance of NF-κB activity between the liver cell compartments in order 
to maintain liver homeostasis and efficiently counteract injury (Luedde, Assmus et al. 
2005; Beraza, Ludde et al. 2007; Luedde, Beraza et al. 2007). Our results suggest 
that interference with this crosstalk might represent a future target for regenerative or 
anti-inflammatory treatment strategies in liver diseases. 
  
Discussion 104 
 In the second part of the thesis, we used hepatocyte-specific Nemo knockout 
mice to assess the role of NF-κB during liver regeneration. Because these mice 
showed impaired NF-κB activation in hepatocytes, the whole liver micro-environment 
is disturbed which led to major remodeling of the liver (Luedde, Beraza et al. 2007; 
Beraza, Malato et al. 2009) Therefore finding the true role of Nemo or NF-κB during 
liver regeneration is a challenging task.  
 
Molecular dissection of Nemo-dependent pathways in hepatocytes 
during liver regeneration 
 
IL-6, STAT3 and hepatoprotection 
Despite the strong inflammation found in untreated NemoΔhepa mice (Luedde, 
Beraza et al. 2007; Beraza, Malato et al. 2009) the priming phase requiring pro-
inflammatory cytokines like TNF-α and IL-6 was impaired. After hepatectomy, TNF-α 
protein level dropped significantly while IL-6 liver expression remained constantly 
low. In addition the transcription factor STAT3, a downstream target of IL-6 signaling, 
was severely reduced in livers of NemoΔhepa mice. Surprisingly, Nemo KO 
hepatocytes could still proliferate. Therefore our work could also have an impact on 
the controversy if TNF-α and/or IL-6 are mandatory to trigger hepatocytes to 
proliferate. Recent work from our group (Dierssen, Beraza et al. 2008) where the IL-6 
receptor gp130 was deleted in hepatocytes showed that IL-6 signaling was not that 
obligatory. A possible explanation is that the process of liver regeneration is so 
important that redundancy of pathways is a natural protection mechanism established 
in the liver during evolution. Furthermore by isolating primary hepatocytes we 
discovered that the receptors needed for IL-6 signaling were strongly down regulated 
on the mRNA level, suggesting an important role for NF-κB in IL-6R and gp130 
transcription. According to our knowledge, this has never been described before but 
we lack molecular mechanisms to further explain this observation at present. 
Yet lack of IL-6 and STAT3 activation might be one of the causes of liver 
failure and the death of the animals occurring in NemoΔhepa mice after partial 
hepatectomy. A recent study (Haga, Terui et al. 2003) reported a hepatoprotective 
role of the IL-6/STAT3 pathway by two mechanisms: a direct inactivation of the 
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caspase cascade by induction of caspase inhibitors (FLIP, BCL-2, BCL-XL) and 
reduction of reactive oxygen species by over expression of the antioxidant protein 
Ref-1. This model could apply to our results (strong down regulation of IL-6 as well as 
STAT3 in NemoΔhepa mice) and suggests that this mechanism further increase the 
oxidative stress mediated liver failure in NemoΔhepa mice. This was further confirmed 
by the strong BCL-2 up regulation seen in BHA treated NemoΔhepa mice which 
restored a survival rate of 100%. One could argue that 70% of the WT mice treated 
with PEITC died after surgery therefore rendering this theory inadequate as WT mice 
should have IL-6 and STAT3 activation after PH.  
Nevertheless, it has been reported by Trachootham et al (Trachootham, Zhou 
et al. 2006) that PEITC induced NF-κB inactivation. Excessive ROS accumulation 
induced by PEITC abrogates certain redox-sensitive molecules such as NF-κB, which 
may contribute to IL-6/STAT3 down regulation and thus compromising cell survival 
signals. Our findings also confirmed in part, the work of the Taub group (Cressman, 
Greenbaum et al. 1996) where 50% of the IL-6-/- mice died after PH. However these 
results are questionable as during their partial hepatectomy surgery they removed 
only two lobes (left lateral and median lobes) to perform their “70% partial 
hepatectomy”. Their method has not been adapted to mice surgery because the 
median lobes are in fact two lobes separated by the gale bladder and they have to be 
removed one at a time to leave the gale bladder intact. By removing the median 
lobes at once, the gall bladder is destroyed and the bile duct integrity is lost, creating 
additional damage to the liver. In this study, 10% of the control mice die after PH 
while 100% of the control mice survive surgery when it is performed in three steps to 
leave the gale bladder intact as recommended in the recent Nature Protocols 
(Mitchell and Willenbring 2008). 
 
Stem Cells and liver regeneration 
 Mice lacking the nemo gene in hepatocytes have already activation of the oval 
cell compartment, a very rare phenomenon in a non-treated liver. When we fed the 
NemoΔhepa animals with a diet containing a toxic xenobiotic which triggers massive 
oval cell expansion (DDC), we obtained a significantly bigger increase in oval cell 
numbers compared to WT mice fed with the same diet, highlighting a predisposition 
for activating oval cells in NemoΔhepa livers. 
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In a healthy liver, partial hepatectomy leads to regeneration of hepatocytes 
through a mechanism of dedifferentiation and then replication of existing hepatocytes 
(Wang, Foster et al. 2003; Fausto 2004; Fausto, Campbell et al. 2006). Upon 
regeneration of the liver following loss of parenchymal cells induced by toxins, such 
as galactosamine (Shinozuka, Lombardi et al. 1978; Lemire, Shiojiri et al. 1991; 
Dabeva and Shafritz 1993) or in the 3,5-dicarbethoxy-1,4-dihydrocollidine (DDC) diet 
model (Petersen, Grossbard et al. 2003; Wang, Foster et al. 2003; Fickert, Stoger et 
al. 2007), replication and differentiation of intrahepatic progenitor cells occurs. The 
extent to which these cells contribute to regeneration varies according to the nature 
and duration of the injury, doses of inducing agents, or other experimental variables. 
After partial hepatectomy, NemoΔhepa mice have a very strong, fast (starting at 3h 
post surgery) and sustained (up to 15d) oval cell expansion, suggesting an important 
role for oval cells during the regeneration process of these mice. This was confirmed 
by the improved survival of NemoΔhepa mice fed with DDC diet reaching 80% of 
surviving animals after partial hepatectomy. By differentiating into ductular 
hepatocytes (intermediate forms between ductular cells and hepatocytes are often 
called ductular hepatocytes), oval cells could help restoring the pool of healthy 
hepatocytes which could further replicate after partial hepatectomy. Although this 
result corroborates our hypothesis, it is still surprising as DDC feeding leads to 
severe liver injury with biliary fibrosis-like symptoms inducing pericholangitis, 
periductal fibrosis, ductular reaction, and consequently portal-portal bridging, down-
regulation of Mrp2 and impaired glutathione excretion, and segmental bile duct 
obstruction (Fickert, Stoger et al. 2007). As DDC feeding is toxic, mice eat less 
compared to mice fed with a regular chow diet. Consequently young mice (4-5 
weeks) fed with DDC diet do not develop nor gain weight properly. Mice weighing 13-
14 grams with a liver of 2 grams do not survive liver surgery. Therefore we changed 
our protocol, and we fed 7-8 weeks old mice so they could endure the surgery after 4 
weeks of feeding. 
A previous report indicated that DDC diet resulted in the secretion of pro-
inflammatory mediators and cytokines such as TNF-α and IL-6 (Subrata, Lowes et al. 
2005). Although an excess of pro-inflammatory cytokines is generally not a good 
prognostic marker for the liver, it might have the beneficial effect of inducing the 
hepatoprotective pathway in the NemoΔhepa mice after partial hepatectomy, resulting 
in an improved survival after surgery. Additional time points would be needed to 
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assess the contribution of IL-6 on improved survival of these animals. However this 
was not the aim of the present study. 
 
NF-κB, oxidative stress and liver regeneration  
Oxidative stress and in particular reactive oxygen species (ROS) have 
deleterious effects on proteins on multiple levels. ROS can affect protein functions 
through deregulation of protein expression, post-translational modifications and 
alteration of protein stability. At the transcriptional level, the expression of signaling 
proteins can be tightly controlled through the modulation of inducible transcription 
factors. A number of transcription factors, such as NF-κB, AP-1, HIF-1α and p53, 
contain redox-sensitive cysteine residues at their DNA-binding site (Trachootham, 
Alexandre et al. 2009). Oxidation of these Cys residues could disrupt the 
transactivation activity and therefore inhibit the expression of the target genes. In a 
previous study (Trachootham, Zhou et al. 2006), Trachootam et al reported reduced 
NF-κB activity in T72Ras cells (T72 cells derived by Ras transformation) pre-treated 
with PEITC after TNF-α stimulation. This finding could explain why Nemof/f treated 
with PEITC die massively after partial hepatectomy. By inhibiting a proper NF-κB 
response, PEITC injection in WT mice mimics what is happening in NemoΔhepa 
animals with hepatoprotection deficiency. Furthermore, NF-kB can regulate 
expression of antioxidants such as ferritin heavy chain (FHC) (Pham, Bubici et al. 
2004) and MnSOD, the Mitochondrial SOD (or SOD2) (Jones, Ping et al. 1997; Xu, 
Kiningham et al. 1999). The superoxide dismutase enzymes are key elements of the 
cellular antioxidant system. 
 
Annexe 11. MnSOD dismutase reactions. The superoxide anion 02- is either transformed into a non-
toxic O2 or a less toxic H2O2. 
We showed that the MnSOD mRNA level was down regulated in whole liver extract 
and notably reduced in NemoΔhepa mice. In addition, although MnSOD doesn’t seem 
to be regulated after partial hepatectomy, it was reduced 3h after PH in PEITC 
treated mice regardless of the genotype (data not shown), confirming a defect of 
MnSOD induction as a result of NF-κB inhibition. A previous report from Kamata et al, 
(Kamata, Honda et al. 2005) depicted a lack of MnSOD after TNF injection, creating 
Discussion 108 
a lack of protection against ROS induced injury in IKK2 knockout fibroblasts. Another 
report also demonstrated a lack of SOD1 and SOD2 on mRNA expression in 
NemoΔhepa livers (Luedde, Beraza et al. 2007).  
The role of oxidative stress during liver regeneration has not been extensively 
analyzed in the past years and our present work sheds some light in the mechanism. 
There are few reports describing the role of oxidative stress during liver regeneration 
with different outcome, highlighting a not fully understood implication of ROS after 
partial hepatectomy, yet. In mice lacking Cybb, a NAPDH oxidase subunit, no 
differences could be seen during liver regeneration (Ueno, Campbell et al. 2006) 
allowing the authors to conclude that Reactive Oxygen Species are not essential for 
liver regeneration after partial hepatectomy. An earlier study involved Uncoupling 
Protein 2 (UCP-2), an inner mitochondrial membrane carrier that senses and 
negatively regulates superoxide production. This paper reported that UCP-2 
deficiency (Horimoto, Fulop et al. 2004) promoted oxidative stress and delayed liver 
regeneration in mice by lack of mitogen activators and delayed DNA synthesis.  
While we cannot directly compare our mice treated with PEITC after partial 
hepatectomy due to high mortality (additional experiments with a lower dose would 
be necessary in that case) the tendency is that after partial hepatectomy increased 
ROS production effectively inhibits liver regeneration as we see less Ki67 positive 
cells in NemoΔhepa mice treated with PEITC 24h after PH compared to control mice. In 
contrast, KO mice treated with antioxidants displayed a proliferation index 
comparable to the WT animals. A more recent work confirmed that ROS is harmful 
during liver regeneration. Partial hepatectomy in Nrf2 knockout mice (Beyer, Xu et al. 
2008) leads to a significantly delayed liver regeneration. The NF-E2-related factor 2 
(Nrf2) is crucial player in the defense against oxidative stress. This transcription 
factor controls the expression of antioxidant proteins and enzymes involved in the 
detoxification of harmful compounds, such as glutathione S-transferase, glutamate-
cysteine ligase catalytic subunit (GCLC) and NAD(P)H quinone oxidoreductase 1 
(NQO1).  
We obtained different results in our mice exhibiting increased ROS before 
partial hepatectomy. We found hepatocytes’ proliferation in WT mice pre-treated with 
PEITC before partial hepatectomy whereas neither UCP-2 nor Nrf2 KO mice showed 
any sign of proliferation. In addition, NemoΔhepa mice after PEITC treatment exhibited 
more proliferation than chow diet fed KO mice and when we fed the same animals 
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with an antioxidant diet, proliferation was almost suppressed from control mice before 
PH, suggesting a positive role of ROS on proliferation confirming previous reports 
(Trachootham, Alexandre et al. 2009). At present we hypothesize that the different 
status of NF-κB within experimental models may explain the different results obtained 
after PEITC injection to induce oxidative stress. 
 
Oxidative stress modulation, cancer and liver surgery 
Hepatocytes lacking nemo can be assimilated as “pre-cancer” cells and livers 
from these mice show a severe disease progression, with all the NemoΔhepa mice 
having HCC after one year (Luedde, Beraza et al. 2007). However these mice 
showed a spectacular improvement after BHA feeding, before surgery as well as 
after partial hepatectomy (reduced liver damage, proliferation, improved survival), 
making BHA a potential therapeutic candidate against cancer. BHA treatment is very 
straightforward and acts by scavenging reactive oxygen species. Oxidative stress is 
reduced, avoiding all the harmful effect of oxidative stress notably DNA damage and 
apoptosis with consecutive proliferation. Moreover NemoΔhepa mice fed with BHA over 
a longer time period have significantly reduced HCC occurrence with only 1 mouse 
developing HCC out of 4 according to the Pasparakis group (personal 
communication, Hamburg 2008, Germany). This result is a strong improvement 
compared to 100% of NemoΔhepa mice fed with chow diet showing HCC after one 
year. It also highlights the powerful adaptation of cancer cells to their environment. A 
larger study would be needed to confirm the interesting promises of this treatment. 
Another radical approach is to use an antioxidant inducer like PEITC. Despite 
the high lethality encountered after partial hepatectomy in mice treated with 
phenethyl isothicyanate, this compound is actually in two clinical trials 
(http://www.clinicaltrial.gov/ct2/results?term=peitc) to test the efficacy against lung 
cancer. The mechanism of action is more complicated, but pretty innovative as 
cancer cells have elevated ROS generation and are under increased intrinsic 
oxidative stress. Thus it is conceivable that these cancerous cells would be more 
dependent on antioxidants for cell survival and, consequently, more vulnerable to 
further oxidative insults induced by ROS-generating agents or by compounds that 
abrogate the key antioxidant systems in cells. The balance between ROS generation 
and elimination maintains the cellular redox homeostasis. Exogenous agents that 
increase ROS generation or decrease antioxidant capacity (like PEITC) will shift the 
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redox balance and result in an overall increase in the level of ROS, which may induce 
cell death if the cells reach their “cellular tolerability threshold”. As therapeutic 
selectivity is essential in cancer treatment, this strategy has the chance to specifically 
target malignant cells.  
 
Annexe 12. Therapeutic approach to selectively kill cancer cells using ROS-mediated mechanisms 
(Trachootham, Alexandre et al. 2009) 
Trachootam et al (Trachootham, Zhou et al. 2006; Trachootham, Zhang et al. 2008) 
and Nogueira et al (Nogueira, Park et al. 2008) successfully used this strategy. In our 
NemoΔhepa mice model, one week of PEITC treatment significantly reduced ALT and 
AST serum level indicating reduced liver damage in NemoΔhepa mice before partial 
hepatectomy. We also found a significantly reduced collagen expression on the 
mRNA and protein level in PEITC livers compared to non treated animals (data not 
shown) suggesting some promising effects as a therapeutic treatment, when surgery 
is excluded. 
PEITC is a natural compound found in cruciferous vegetables, like cabbage. 
Western countries are not big consumers of these vegetables unlike eastern 
countries like China and especially Japan. Even if the amount injected in mice was 
far from being physiological, a risk may exist that a patient suffers from liver failure 
after liver surgery because of the high oxidative stress level before surgery. Our 
results highlight the absolute necessity of controlling the level of oxidative stress in 
patient undergoing liver surgery. Moreover, the use of diet containing antioxidants as 
a pre-operative treatment may reduce complication after liver surgery especially in 
Asian populations which have a high prevalence of viral hepatitis.  
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NF-κB modulation during liver regeneration 
IKK2 is the main kinase activating NF-κB in the classical pathway. However 
when IKK2 is blocked, IKK1 can take over its role and as a result the activation of 
NF-κB is delayed and reduced as showed in IKK2Δhepa mice. Yet these mice have a 
faster regeneration due to a stronger Acute Phase Response giving an advantage 
over WT mice. This benefit was however not found when we applied the IKK2 
inhibitor AS602868 systemically, blocking IKK2 in all the cells of the body and also in 
the liver (Frelin, Imbert et al. 2003; Frelin, Imbert et al. 2005; Beraza, Malato et al. 
2008).  
Half of the mice lacking nemo in hepatocytes are dying after partial 
hepatectomy, but we showed that it could be completely overcome by supplementing 
the animals’ diet with the antioxidant BHA. Additionally, BHA feeding restored 
hepatocyte proliferation in NemoΔhepa mice. The lack of NF-κB activation in 
hepatocytes alters liver homeostasis and modifies its microenvironment in NemoΔhepa 
mice (Luedde, Beraza et al. 2007; Beraza, Malato et al. 2009) (Annexe 13).  
Indeed, cells in the liver are constantly exposed to toxic substances that need 
to be detoxified and to microbial pathogen-associated molecular patterns that 
originate from the intestine and reach the liver through the portal circulation. These 
toxic components can damage liver parenchymal cells, the hepatocytes and also 
activate Kupffer cells to secrete pro-inflammatory cytokines. NF-κB activation 
provides survival signals that protect hepatocytes from toxic compounds and also 
from cytokines secreted by Kupffer cells. NF-κB inhibition sensitizes hepatocytes to 
death-inducing signals, triggering liver inflammation and compensatory hepatocyte 
proliferation, and ultimately resulting in the development of hepatocellular carcinoma. 
Therefore in 8 weeks old nemo hepatocyte-deleted animals, the liver is 
already remodeled rendering harder to differentiate between the contributions of the 
inflamed liver or the sole lack of NF-κB activation in hepatocytes when the liver is 
challenged by partial hepatectomy. The study of Iimuro et al showed apoptosis and 
impaired hepatocyte proliferation after partial hepatectomy when the adenoviral 
vector was applied (Iimuro, Nishiura et al. 1998). One of the critics of this study was 
that using the adenoviral vector triggered apoptosis and DNA synthesis already 
before PH. As described in the recent literature (Luedde, Beraza et al. 2007), this 
phenotype might not be related to the adenovirus itself, but is rather an intrinsic 
phenotype resulting of a complete blockade of NF-κB in hepatocytes.  
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Annexe 13. NF‑κB inhibition in liver parenchymal cells causes hepatitis and hepatocellular carcinoma. 
(Pasparakis 2009) 
 
In the end, our results using a more sophisticated model to block NF-κB are 
consistent with the 11 years old original study from Iimuro, but our work adds another 
player in the liver regeneration field, oxidative stress. By bringing a better 
understanding of the basal phenotype of the NemoΔhepa mice (Annexe 14)  
  
Annexe 14. Oxidative stress and its consequences on NemoΔhepa mice basal phenotype. 
Discussion 113 
 
as well as the role of Nemo during liver regeneration (Annexe 15), this thesis 
highlights, once again, the tremendous contribution of NF-κB to liver homeostasis 
and the absolute necessity of its tight regulation. 
  
Annexe 15. Oxidative stress and its consequences on NemoΔhepa mice after partial hepatectomy. 
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Summary V 
7. Summary 
The transcription factor NF-κB is essential for liver homeostasis. The IKK 
complex (composed by two catalytic subunits IKK1 and IKK2 and a regulatory 
subunit Nemo) tightly regulates NF-κB activity. In the present work, we modulated 
NF-κB activity in the liver by using hepatocyte-specific IKK2 (IKK2Δhepa) and 
hepatocyte-specific Nemo (NemoΔhepa) knockout mice and analyzed the role of the 
IKK complex in the context of liver regeneration. 
Partial hepatectomy (PH) in IKK2Δhepa mice led to a delayed and reduced NF-
κB activation. Consequently, the proinflammatory cytokine TNF-α was strongly 
induced earlier in IKK2Δhepa mice and the Acute Phase Response marker SAA 
showed an early and strong mRNA activation in KO compared to WT mice. In 
addition, PolyMorphoNuclear cells were recruited massively in IKK2Δhepa liver 12h 
after hepatectomy. As a result of all these early events, IKK2Δhepa mice showed 
earlier hepatocytes proliferation compared to wt animals. These mechanisms would 
contribute to faster liver regeneration observed in IKK2Δhepa mice.  
50% of NemoΔhepa mice died during the regeneration process while all WT 
animals survived as expected. After PH, priming was impaired in NemoΔhepa mice 
with TNF-α and IL-6 liver protein levels both downregulated. This led to a blunted 
kinetic during liver regeneration in NemoΔhepa mice with a low and constant rate of 
proliferation. Furthermore, oval cells were unusually activated shortly after PH in 
NemoΔhepa mice, highlighting an important role for this cell population. This was later 
on confirmed by DDC diet-induced pre-expansion of oval cells which improved the 
survival of NemoΔhepa mice after PH despite inherent toxicity of the food. Oxidative 
stress plays an important role in NemoΔhepa mice livers before and especially after 
liver surgery. Butylated hydroxyanisole (BHA, an antioxidant) supplemented diet 
resulted in a significantly reduced liver damage before and after PH. Additionally, 
BHA feeding restored hepatocyte proliferation in NemoΔhepa livers and resulted in 
100% survival after PH. In contrast, mice treated for 1 week with phenethyl 
isothiocyanate (PEITC), an oxidative stress inducer, showed significantly higher liver 
damage after PH and moreover, all PEITC-treated NemoΔhepa mice died within 3 days 
after PH. Partial hepatectomy is highly challenging for NemoΔhepa mice. Modulating 
the oxidative stress level directs the outcome of NemoΔhepa mice after partial 
hepatecomy. By adapting the proliferative response, oxidative stress has a major 
impact on the phenotype observed in these animals. 
Résumé  VI 
8. Résumé 
 
Rôle du complexe IKK pendant la régénération hépatique 
 
 Le facteur de transcription NF-κB est essentiel pour l'homéostasie du foie. Le 
complexe IKK (composé de deux sous-unités catalytiques IKK1 et IKK2 et une sous-
unité régulatrice Nemo) régule finement l'activation de NF-κB. Dans le présent travail, 
nous avons modulé l'activité de NF-κB dans le foie en utilisant des souris 
conditionnelles KO pour les cellules hépatiques du foie pour IKK2 (IKK2Δhepa) et 
Nemo (NemoΔhepa). Nous avons analysé le role du complexe IKK durant la 
régénération hépatique.  
 L'hépatectomie partielle (PH) dans les souris IKK2Δhepa résulte dans une 
réduction et une atténuation de l'activation de NF-κB. Conséquemment, la cytokine 
pro-inflammatoire TNF-α est fortement induite et ce plus rapidement dans les souris 
IKK2Δhepa et le marqueur de protéine de phase aigüe SAA démontre une activation 
plus rapide et plus forte au niveau de l'ARN messager dans les souris KO comparés 
aux souris WT. En outre, les cellules polynucléaires de types neutrophiles sont 
recrutés massivement dans le foie des souris IKK2Δhepa 12h après hépatectomie 
partielle. En conséquence de tout ces évènements survenant assez tôt durant le 
processus de régénération hépatique, les cellules hépatiques des souris IKK2Δhepa 
prolifèrent plutôt que les hépatocytes des souris WT. Ces mécanismes contribuent à 
une régénération hépatique plus rapide observée dans les souris IKK2Δhepa . 
 50% des souris NemoΔhepa  meurent durant la régénération hépatique alors 
que toutes les souris WT survivent l'acte chirurgical comme prévu. Après 
hépatectomie partielle, le processus d'initiation de la prolifération est sévèrement 
détérioré dans les souris NemoΔhepa car les protéines TNF-α et IL-6 sont très 
fortement sous exprimées dans le foie. Ceci conduit à une cinétique de prolifération 
complètement modifiée avec un niveau de prolifération constant et plutôt bas. De 
plus, les cellules ovales du foie sont anormalement activées très rapidement après 
hépatectomie partielle dans les souris NemoΔhepa soulignant un rôle important pour 
cette population cellulaire. 
 Le stress oxidatif joue un rôle très important dans le foie des souris NemoΔhepa 
avant mais surtout après chirurgie du foie. Un régime alimentaire complementé avec 
du Butylated hydroxyanisole (BHA, un antioxidant) donné aux souris NemoΔhepa 
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résulte en une diminution des damages du foie avant et après hépatectomie partielle. 
En addition, régime riche en BHA restaure une prolfération hépatique normale et 
surtout une survie de 100 après chirurgie. A l'opposé, les souris traitées pendant une 
semaine avec du phenetyle isothiocyanate (PEITC), un inducteur du stress oxidatif, 
montrent des dommages liés au foie très supérieurs apèrs hépatectomie partielle et 
surtout toutes les souris NemoΔhepa traitées au PEITC meurent dans les 3 jours 
suivant la chirurgie. 
En modulant le niveau de stress oxidatif des souris NemoΔhepa nous arrivons à 
moduler la survie de ces animaux après hépatectomie partielle. En adaptant la 
réponse proliférative, le stress oxidatif à un impact majeur dans le phénotype 
observé dans les souris NemoΔhepa. 
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9. Abbreviations 
A 
AA amino acid 
Ab antibody 
add addition 
AFP α-fetoprotein 
Alfp albumin/α-fetoprotein 
ALT alanine-aminotransferase 
AP-1 activator protein 1 
APG acute phase genes 
APR acute phase response 
APS ammonium persulfate 
AST aspartate-aminotransferase 
ATP adenosine triphospate 
 
B 
BCL-2 B-cell lymphoma 2 
BHA butylated hydroxyanisole 
Bp basepairs  
BrdU 5-bromo-2'-deoxy-uridine 
BSA bovine serum albumin 
 
C 
cDNA complementary DNA 
Cdc cell division cycle (also known as Cdk) 
Cdk Cyclin-dependent kinase 
c-Kit CD117 or c-Kit receptor 
cm centimeter 
Cre causes recombination 
Ct threshold 
CTP cytidintriphospate 
Ctrl control 
Cybb cytochrome B beta 
 
Abbreviations  IX 
D 
d days 
Δde fe ctive 
d distilled 
DAB diaminobenzidine 
dATP desoxyadenosintriphospate 
dCTP desoxycytidintriphospate 
DDC 3,5-diethoxycarbonyl-1,4-dihydro-collidine 
DEPC diethyl pyrocarbonate 
dGTP desoxyguanosintriphospate 
DHE Dihydroethidium (hydroethidine) 
DMEM Dulbecco's Modified Eagle Medium 
DNA deoxyribonucleic acid 
dNTP desoxyribonucleosidtriphosphate 
ds double-stranded 
DSBs double-strand breaks 
DTT dithiotreitol 
dTTP desoxythymidintriphospate 
 
E 
E extinction 
ECL enhanced chemiluminescence 
ECM extracellular matrix 
EDTA N,N;N’,N’-ethylendiamine-tetraacetate 
e.g. for example lat. exempli gratia 
EGTA ethylen glycol-bis (2-aminoethyl)- N,N;N’,N’- tetraacetate 
ELISA enzyme linked immunosorbent assay 
ES (cells) embryonic stem (cells) 
EtBr ethidium bromide 
 
F 
FCS fetal calf serum 
FACS fluorescent activated cell sorting 
FADD Fas-associated death domain 
Abbreviations  X 
FLICE FADD-like interleukin-1b-converting enzyme 
FLIP FLICE-inhibitory protein 
 
G 
G gap 
G gauge 
g acceleration of gravity 
g gram 
GAPDH glycerinaldehyde-3-phosphate-dehydrogenase 
gp glycoprotein 
GPX glutathione peroxidase 
GR glutathione reductase 
GRX glutaredoxin 
GSH glutathione 
 
H 
h hours 
H&E hematoxylin/eosin 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HGF hepatocyte growth factor 
HIF-1 hypoxia-inducible factor 
HNF4-α hepatocyte nuclear factor 4 α 
HRP horseraddish peroxidase 
 
I 
IFN interferon 
IκB Inhibitor of kappa b 
IKK I kappa b kinase 
 
IL interleukin 
i.p. intraperitoneal 
 
J 
JNK c-Jun N-terminal kinases 
Abbreviations  XI 
 
K 
kDa kilo Dalton 
KC keratinocyte-derived cytokine (CXCL1) 
kg kilogram 
 
L 
L liter 
loxP locus of crossing over 
LPS lipopolysaccharide 
 
M 
M Mol 
mA milliampere 
mCi millicurie 
μg microgram 
min minute 
ml milliliter 
μl microliter 
M-MLV Moloney-murine leukemia virus 
mm3 cubic millimeter 
μM micromolar 
mmol millimolar 
μm micrometer 
μmol micromolar 
MOPS 3-[N-Morpholino] propanesulfonic acid 
mRNA messenger RNA 
 
N 
N Normal 
NADPH oxydase nicotinamide adenine dinucleotide phosphate-oxidase 
NCF1 neutrophil cytosolic factor 1 
Nemo NF-κB essential modulator 
NF-κB nuclear factor-kappa B 
Abbreviations  XII 
ng nanogram 
NIH National Institutes of Health 
nm nanometer 
NPC non parenchymal cell 
Nrf2 NF-E2-related factor 2 
 
O 
OD optical desity 
ORF open reading frame 
 
P 
p- phospho- 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PEITC phenetyl isothiocyanate 
PH partial hepatectomy 
pH potentia hydrogenii 
pIpC poly-inosin-poly-cytidilin 
PMN polymorphnuclear leukocytes (mainly neutrophils) 
PMSF phenylmethyl sulfonyl fluoride 
P/S penicillin/streptomycin 
 
Q 
Q glutamine 
 
R 
R receptor 
Ras rat sarcoma 
ROS reactive oxygen species 
Rpm revolutions per minute 
RT reverse transcription 
 
S 
SAA serum amyloid A 
Abbreviations XIII 
SD standard deviation 
SDS sodium dodecyl sulfate 
SOCS3 suppressor of cytokine signaling 3 
SOD superoxide dismutase 
STAT signal transducer and activator of transcription 
 
T 
Taq Thermus aquaticus 
TBS Tris-buffered saline 
TE Tris-EDTA 
TGF transforming growth factor 
Thr threonine 
TNF tumor necrosis factor 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling 
Tyr tyrosine 
 
U 
U unit 
UCP-2 Uncoupling protein 2 
UKA Universitätsklinikum Aachen 
 
V 
vs. Versus 
 
W 
WBC white blood counts 
X 
 
Y 
Y tyrosine 
 
Z 
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